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Abstract 
Tuberculosis (TB), a transmissible disease caused by Mycobacterium 
tuberculosis (Mtb), is a global health threat. To design an effective vaccine, we 
need to better understand how different elements of our immune system 
collaborate to fight against Mtb. CD4 T cells are crucial in protective immunity to 
Mtb because they produce cytokines including interferon-γ. In contrast, CD8 T cells 
are thought to play a modest role. Whether CD4 T cells act as “helper” cells to 
promote optimal CD8 T cell responses during TB is unknown. We argue CD8 T 
cells’ role are likely underestimated because CD8 T cell functions are 
compromised without CD4 T cells. Here, using two independent models, I show 
that CD4 T cell help promotes CD8 T cell effector functions and prevents CD8 T 
cell exhaustion. I demonstrate CD4 and CD8 T cells synergistically enhance the 
survival of infected mice. Purified helped, but not helpless, CD8 T cells effectively 
restrict intracellular Mtb growth. Thus, CD4 T cell help is indispensable for 
generating protective CD8 T cell responses. In addition, I investigate the 
mechanisms of CD4 T cell help. Signals from CD4 T cells, and signals relayed by 
antigen presenting cells collectively shape CD8 T cell responses. We infer that 
vaccines aimed for eliciting both CD4 and CD8 T cells, in which CD8 T cells are 
properly helped by CD4 T cells, are more likely to be successful.   
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CHAPTER I: INTRODUCTION 
 
 
Global Tuberculosis Burden 
 
 
Tuberculosis (TB), caused by pathogen Mycobacterium tuberculosis (Mtb), 
is a transmissible disease. It’s estimated that a quarter of global population is 
latently infected [1]. In 2019, about 10 million people worldwide fell ill with TB, and 
cases occurring in South-East Asia and Africa accounted for 70% of the new cases 
[1]. TB was the leading cause of death from a single infectious agent before the 
start of the COVID-19 pandemic. It claimed 1.4 million deaths in 2019, and the 
number is estimated to increase in 2020 because of health service disruption 
during COVID-19 pandemic [1].    
TB is transmitted via aerosol droplets that contain Mtb. Once patients with 
pulmonary TB cough, sneeze, or shout, these infectious droplets are expelled, and 
inhaled by exposed individuals to establish infection. Most infected people don’t 
develop symptoms, a stage called latent tuberculosis infection (LTBI) [2-4]. It is 
characterized by a contained infection, and it’s not transmissible during this state. 
However, 10% of infected people will progress into active, symptomatic disease, 
and experience chronic cough, coughing with bloody mucus, weight loss, and 
fatigue. Active TB disease can transmit among people. TB mostly affects the lungs, 
although extrapulmonary TB can occur [5, 6]. Risk factors to develop active TB 
include HIV infection, diabetes, immunocompromised conditions, and 
undernutrition. The first two years after initial infection has the highest likelihood of 
progressing to active disease [7].  
Despite all the resources and efforts that have worked to put an end to the 
TB epidemic, we have yet to succeed. The World Health Organization (WHO) 
developed a  strategy to reduce 90% of new cases and 95% of TB deaths by 2035 
[1]. TB incidence rates has indeed slowly decreased each year, but the decrease 
is not enough to achieve the set goal [1]. Additionally, the reduction in TB deaths 
is even slower. This perhaps reflects the challenge of TB treatment. Although TB 
is a curable disease, only about 85% of people who develop TB can be 
successfully treated, and it takes months to complete the medicine regimen. 
Depending on the individual case, the regimen could take six to nine months with 
four different antibiotics: Isoniazid, Rifampin, Ethambutol, and Pyrazinamide.  
Patient non-adherence to the regimen has been the major difficulty to treating TB. 
Moreover, the emergence of multidrug-resistant tuberculosis (MDR-TB) further 
complicates the situation. In fact, the cases of MDR-TB increase each year and 
have become a public health crisis in itself [1].  
Prophylactic vaccination is an alternative strategy to reduce global TB 
burden and combat the challenge of treatment. There is one approved vaccine for 
TB, Bacille Calmette-Guerin (BCG), an attenuated strain derived from 
Mycobacterium bovis. BCG has been introduced almost a century ago, and it’s the 
most widely used vaccine worldwide, but it seems to have minimal effect on 
reducing the global TB burden. Indeed, the efficacy of BCG is controversial. 
Although BCG consistently confers great protection in infants and toddlers to 
prevent severe meningeal TB and miliary TB, its efficacy against adult pulmonary 
disease varies among populations [8]. It’s thought that prior sensitization with other 
Mycobacteria, which often occurs in people living in low latitude areas, and the 
heterogeneity of BCG strains used in vaccination attributes to the inconsistent 
efficacy [9-11]. Thus, a more effective vaccine is needed to halt the TB pandemic. 
Researchers didn’t hesitate in searching for alternative vaccines, and in fact, 
several candidates are currently in clinical trials [12]. However, we’ve yet to have 
a vaccine that can replace BCG. The biggest hurdle remains the incomplete 
understanding of protective immunity during  both primary infection and vaccine 
induced protection [13]. A better delineation of protective immune responses to 
Mtb is essential to facilitate vaccine development.     
 
Immunity to Tuberculosis 
 
Early events 
Mtb travels with aerosol droplets and accesses distal lung alveoli, where it 
establishes infection. Like during all the other infections, innate immune cells are 
the first line of defense against Mtb. Despite the early innate immune responses, 
Mtb burden increases rapidly in lung during the first few weeks after infection, an 
observation from experimental animal models, suggesting these cells are unable 
to control infection on their own. Nevertheless, these early events occurred before 
adaptive immune responses have been shown to enormously impact the 
pathogenesis of TB. Mtb first infects and replicates in alveolar macrophages (AMs) 
in lung alveoli, and then spreads to other resident and recruited myeloid cells 
including macrophages, dendritic cells (DCs), and neutrophils. Not until recently 
did we start to appreciate the heterogenicity of myeloid cells in infected lungs and 
the complex responses they have to Mtb. Using multi-color flow cytometry and the 
fixable fluorochrome Mtb, several groups studied the distribution of Mtb in myeloid 
cells early during infection [14-16]. It is now clear that some populations harbor 
more Mtb compared to others. Depending on the dose, route, and timing of 
infection, and the flow cytometry panel used to distinguish myeloid cells, CD11chi 
monocyte derived cells, neutrophils, and CD64+Mertk+ interstitial macrophages are 
reportedly the major infected cells [14-16]. This unequal distribution of Mtb 
supports the idea that Mtb establishes a niche for its replication. Whether the 
niches form because certain cells are intrinsically more permissive or/and they are 
less responsive to adaptive immunity remains unknown.  
The established infection then leads to Mtb dissemination, through infected 
DCs or extracellular Mtb, to lung draining mediastinal lymph nodes (MLN), which 
initiate T cell responses. T cell priming occurs 8-9 days after infection. Once Mtb 
is found in MLN, Mtb-specific IFNγ responses can be detected [17]. Naïve T cell 
activation, measured  by proliferation and CD69 expression, is also detectable in 
MLN [18, 19]. The activated effector cells then migrate toward the lung, which 
occurs 15-18 days after infection, and finally reach the lung with sufficient effective 
responses to stop the rapid replication of Mtb 18-20 days after infection. 
The delayed T cell priming and arrival to lungs contributes to the 
establishment of Mtb infection. This is supported by the observation that 
dissemination occurs  earlier in resistant C57BL/6 mice, generating faster Mtb-
specific responses, than in susceptible C3H mice [17]. Why T cell priming is 
delayed is not entirely clear. This may be because of the slow growing nature of 
Mtb, which doubles after/in about 24 hours in vitro, leading to slow dissemination 
and delayed priming. However, even with high dose infection, the dissemination is 
only accelerated for 1-2 days [18]. It’s thought that the poor migratory ability of DCs 
residing in lung alveoli, and the more tolerogenic environment contribute to the 
slow dissemination [20].      
Despite arriving late, T cells contain Mtb replication and the bacterial loads 
in lungs reach a stationary phase. This restriction is associated with T cells, along 
with recruited B cells and myeloid cells, to “wall off” Mtb by forming a unique 
structure called granuloma, the hallmark of TB. The granuloma is an aggregate of 
organized immune cells, which has a necrotic center composed of dead and dying 
macrophages containing Mtb. Surrounding cells of this necrotic center are 
transformed cells of macrophages, including foam cells, multinucleated giant cells, 
and epithelioid cells. T cells, B cells, and DCs are at the outer edge. This compact 
structure creates a harsh environment that is low of oxygen and nutrients for the 
Mtb inside. However, being a pathogen that coevolved with humans for thousands 
of years, Mtb can enter  a “dormancy” state in response [21]. Although it normally 
replicates slowly, Mtb can even switch to a non-replicating and metabolic stable 
phase to persist in the host. Therefore, a chronic infection is established, in which 
T cells can effectively contain, but cannot eliminate persistent Mtb.    
 
The role of CD4 T cells in immunity to Mtb 
CD4 T cells’ crucial role in immunity to TB has been established back in the 
1980s. T cells, but not antibodies, are found to mediate protection against Mtb, 
and these cells are then identified as CD4 T cells [22, 23]. This is supported by 
later findings that mice deficient in CD4 T cells succumb early after infection [24], 
and an “experiment of nature” that AIDS patients have higher risk of developing 
active tuberculosis [25]. Moreover, the ability to produce IFNγ is thought to be the 
mechanism of CD4 T cell mediated protection. IFNγ activates infected 
macrophages. Activated macrophages then trigger several antimicrobial pathways, 
including inducible nitric oxide synthase (iNOS), IFNγ-inducible GTPases, 
phagosome maturation and acidification, autophagy, and vitamin D receptor 
signaling [26-31]. Indeed, IFNγ deficient mice are extremely susceptible to 
infection [32, 33]. Therefore, CD4 T cells producing IFNγ and the consequential 
activation of macrophages is the “central dogma” of protective immunity to Mtb [4].  
Because of the strong correlation between IFNγ producing CD4 T cells and 
protection, vaccines are designed to generate strong IFNγ+ CD4 T cell responses 
(i.e., Th1 responses) [34, 35]. However, MVA85A, a vaccine that produced durable 
Th1 responses, failed to enhance protection in the BCG-vaccinated population [36]. 
Recent studies in animal models reveal that IFNγ producing CD4 T cells, although 
they are necessary, are not sufficient for protection. In mice, IFNγ has modest 
effect on controlling Mtb burden in the lung, despite it mediating great control in 
the spleen [37]. Increased ability of IFNγ production by CD4 T cells exacerbates 
lung infection and leads to early mortality of mice [37]. This “required”, but not 
“sufficient” role of IFNγ producing CD4 T cells perhaps explains the conflicted 
results in searching for immune correlates of protection after BCG vaccination in 
humans. While some studies indicate BCG induced IFNγ production correlates 
with protection [38], other studies don’t find association between Th1 cytokine 
producing T cells and the reduced risk for TB [35, 36, 39].  
It’s clear that explanations beyond the narrow focus on IFNγ producing CD4 
T cells are necessary to understand protective immunity, and to identify new 
biomarkers needed for vaccine development. Therefore, other subsets of CD4 T 
cells and their contribution to protection have been studied. Th17 cells can inhibit 
bacterial growth when adoptively transferred into mice [40]. Th17 cells are 
associated with vaccine induced protection [41-44]. They populate lungs after 
vaccination and enhance the recruitment of IFNγ producing CD4 T cells upon 
challenge [45]. In addition, T helper cells expressing both Th1 and Th17 features, 
the Th1* or ex-Th17 cells, are found during Mtb infection [46-48]. Th1* cells are 
IFNγ+CXCR3+CCR6+ cells that co-expressing T-bet and RORgt [49], whereas ex-
Th17 cells are tissue resident memory cells that derived from previous IL-17 
producing cells during infection [50]. The CXCR3+CCR6+CCR4- cells are found in 
peripheral blood of latently infected patient, suggesting a protective role during TB 
[47, 48]. Moreover, CD4 T cells that produced multiple cytokines, polyfunctional 
CD4 T cells, are shown to be protective. In a mucosal BCG study in non-human 
primate (NHP), the induction of polyfunctional CD4 T cells producing IFNγ, TNFa, 
IL-2, and IL-17 are associated with protection [51]. Interestingly, MVA85A induced 
CD4 T cells producing IFNγ, TNFa, and IL-2, but this vaccine didn’t confer 
protection [36]. The search for new biomarkers that correlated with protection 
remains a direction for future study. 
 
The role of CD8 T cells in immunity to Mtb 
The essential role of CD8 T cells 
CD8 T cells are recognized as an integral part of immunity to Mtb. Mtb 
specific CD8 T cells are detected in people with prior BCG vaccination and LTBI, 
and even patients with active disease [52-55]. Early studies derived CD8 T cell 
lines from these samples for functional studies and showed specific CD8 T cell 
responses are generated. Nevertheless, the first evidence that CD8 T cells 
contribute to protective immunity to Mtb came from murine models. I.M. Orme in 
the 1980s showed lymphocytes from BCG-immunized mice were able to transfer 
protection to immunodeficient mice [56]. Using this approach, he further examined 
CD8 T cells’ role with fractionized lymphocytes by depleting CD4 or CD8 T cells 
before transfer  [57, 58]. Adoptively transferred CD8 T cells can mediate protection 
in lungs and spleens in immunodeficient mice against subsequent infection [57-
60]. Antibody mediated depletion of CD8 T cells in vivo is another approach to 
determine whether CD8 T cells transfer protection. Indeed, mice depleted of CD8 
T cells have higher bacterial burden in spleens after iv infection [61]. Although CD8 
T cells are proved to play a role in immunity to Mtb, the magnitude of protection 
they mediate varies between models where different strains and routes of infection 
were used [61-63].  
The use of knockout (KO) mice in the 1990s confirms the indispensable role 
of CD8 T cells in response to Mtb. By disruption of the expression of MHCI 
molecules on cell surface, and disabling  the development of MHCI-restricted CD8 
T cells, β2-microglobulin (β2m), transporter associated with antigen processing-1 
(TAP-1), and MHCI heavy chain (KbDb) KO mice were used to determine the role 
of CD8 T cells [64-66]. These mice die prematurely after Mtb infection, highlighting 
the role of CD8 T cells. Interestingly, the susceptibilities of these mice to Mtb are 
different. The β2m KO mice are the most susceptible and they succumb rapidly 
after iv infection [66]. Although suggesting the role of CD8 T cells, the susceptibility 
of β2m KO mice is complicated by the involvement of β2m in the expression of 
CD1 and class Ib MHC molecules, which also presents Mtb antigens. To test 
whether the absence of CD1-restricted, or MHCI-restricted CD8 T cells contribute 
to the susceptibility of β 2m KO mice, Behar and colleagues compared the 
susceptibility of CD1 KO mice to TAP-1 KO mice, and found TAP-1 KO mice, but 
not CD1d KO mice had impaired resistance to Mtb [64]. This result again 
evidenced the crucial role of MHCI-restricted CD8 T cells.  
Although it’s clear that CD8 T cells play a role in protective immunity to Mtb, 
their relative importance compared to CD4 T cells is questioned. In the adoptive 
transfer models, where CD8 T cells mediate various magnitudes of protection in 
spleens of immunodeficient mice, CD4 T cells consistently confer significant 
protection in both lungs and spleens of recipient mice [61-63]. In a well-controlled 
study performed by Mogues and colleagues, mice depleted of CD4 T cells 
succumbed soon after low dose aerosol infection, while mice depleted of  CD8 T 
cells survived much longer than mice deficient in CD4 T cells [24]. However, CD4 
T cells have shown to be necessary for optimal CD8 responses in many infections 
and cancers;  what is called CD4 T cell help [67, 68]. CD8 T cells’ relative 
contribution could be underestimated in the models in which they were assayed 
alone, because CD8 T cells’ function could be compromised without CD4 T cells. 
This part is addressed in later sections. 
The lack of evidence in humans for the requirement of CD8 T cells in 
immunity to TB makes the contention even more complicated. The higher risk of 
primary and reactivated TB in AIDS patient strongly argues the importance of CD4 
T cells [69-71], while no similar situation of  humans specifically deficient in CD8 T 
cells exposed to  TB to provide the argument for CD8 T cells. Non-human primates 
(NHP) are thought to be more relevant models for TB study because NHP capture 
a diverse spectrum of disease (i.e., active and latent tuberculosis), and form 
granulomas that are not typically found in murine models. NHP also share immune 
features with humans that mice or rodents don’t have, including  orthologues of 
genes for group 1 CD1 antigen presenting molecules and cytotoxic protein 
granulysin [72, 73]. These features make NHP strong candidates to study CD8 T 
cells. Indeed, cytokine producing CD8 T cells are found within granulomas in NHP 
[74]. 
Recent data from NHP emphasized the crucial role of CD8 T cells in vaccine 
induced protection and primary infection [75-78]. The strongest evidence came 
from Chen and colleagues’ study in which they conducted antibody mediated 
depletion of CD8 T cells in BCG vaccinated rhesus macaques. BCG induced 
protection was largely compromised in anti-CD8 treated, BCG immunized 
macaques [78]. In addition, several vaccine strategies induce strong memory CD8 
T cell responses, including intravenous administration  of BCG (iv BCG) [76], CMV 
vectors expressing TB antigen [77], and aerosolized Mtb ∆ sigH [79]. These 
vaccines confer significant protection to challenge in rhesus macaques. Although 
it’s hard to establish the immune correlates of protection from these studies, these 
results shed light on the role of CD8 T cells in vaccine mediated protection. Fewer 
studies address CD8 T cells’ role in primary infection in NHP models. Nevertheless, 
Gideon and Hughes recently identified protective features by comparing cellular 
composition in restrictive vs. permissive granulomas using scRNA-seq. In this 
study, CD8 T cells with cytotoxic features were correlated with restriction of Mtb 
growth in granulomas. This study indicated that CD8 T cells are also essential in 
primary infection [80].  
 
CD8 T cell effector functions 
Despite evidence showing that CD8 T cells play a vital/significant role in 
protective immunity to Mtb, how CD8 T cells mediate protection is not clear. CD8 
T cells can make cytokines that are known to contribute to immunity against Mtb, 
including IFNγ, TNF, IL-17, and IL-2. However, CD4 T cells can also secrete these 
cytokines, and are the main producers in most cases. This raises a question 
whether CD8 T cells have a unique role during Mtb infection. Cytotoxicity function 
is thought to be a distinct function of CD8 T cells in many viral  infections and 
cancer, but it hasn’t been appreciated in Mtb infection until recently [75].  
IFNγ has a well-established role in host resistance to Mtb. IFNγ and IFNγR 
KO mice are extremely susceptible in Mtb infection [32, 33]. CD8 T cells derived 
from infected experimental animals and TB patients produce IFNγ in vitro [81-84]. 
In fact, IFNγ secretion by CD8 T cells is regularly used as a readout for screening 
the responses to Mtb antigens, including the use of interferon-gamma release 
assay (IGRAs) for LTBI diagnosis.  Using a direct intracellular staining technique, 
Bold and colleagues assayed IFNγ ex vivo without stimulation, and showed CD8 
T cells were a major producer of  IFNγ in the lungs of Mtb infected mice, with IFNγ 
production second only to CD4 T cells [85]. Similarly, Caruso and colleagues 
showed the amount of IFNγ in lungs only transiently decreased in CD4 KO mice, 
and CD8 T cells were the producers of IFNγ in these mice [86]. Interestingly, two 
other studies found that CD8 T cells’ ability to produce IFNγ depended on CD4 T 
cells [85, 87]. Whether IFNγ produced by CD8 T cells contributes to their protection 
against Mtb is a harder question to answer. Tascon and colleagues found 
adoptively transferred WT CD8 T cells, but not IFNγ KO CD8 T cells protected 
nude mice from Mtb infection [59]. However, whether IFNγ production is required 
for CD8 T cell transferred protection in intact mice remains unanswered.  
TNFa is another effective cytokine during Mtb infection. In addition to data 
acquired from experimental animals, the increased incidence of TB in autoimmune 
disease patients that received TNFa blocking treatment also highlights the role of 
TNFa in immunity to Mtb [88, 89]. TNFa can act synergistically with IFNγ to activate 
infected macrophages for Mtb killing [90, 91]. Infected macrophages, CD4 T cells, 
and CD8 T cells isolated from infected experimental animal and TB patient can 
produce TNFa [92, 93]. As discussed for IFNγ, whether CD8 T cells mediate 
protection in vivo through TNFa production is unknown.  
CD8 T cells are called cytotoxic T lymphocytes (CTL), highlighting their 
unique function of cytolysis. Cytolysis induced apoptosis can restrict Mtb growth 
by promoting the engulfment of dead cells by uninfected macrophages (i.e., 
efferocytosis) [94, 95]. Cytolysis has been shown in vitro when cell lines derived 
from Mtb infected patient or experimental animal recognize and kill target cells [53, 
81, 96]. In addition, by differential fluorescent-labeling of target cells that were Mtb 
peptide pulsed or non-pulsed, and transferred into infected or uninfected mice, the 
cytotoxicity function of CD8 T cells can be measured based on the ratio of peptide 
pulsed vs. non-pulsed target cells in infected versus uninfected. Using this CTL 
assay, Mtb specific CD8 T cells’ cytotoxic activity in vivo was detected [83, 97]. 
CD8 T cells can lyse target cells through several molecular mechanisms: 1. 
Release of cytotoxic granules; 2. CD95-CD95L (Fas-FasL) dependent cytotoxicity; 
3. TNFa induced apoptosis. Although the usage of these cytotoxic pathways by 
CD8 T cells has been studied using derived CD8 T cell lines [53, 98, 99], the 
relative importance of these mechanisms in vivo are controversial. Both granzyme 
and perforin KO mice show no impairment  in Mtb growth control [100], although 
perforin KO mice succumb earlier than WT mice in a study using iv infection [65]. 
The mice deficient in CD95-CD92L pathway don’t have a defect in controlling Mtb 
growth at early timepoints after infection, but have higher bacterial burden in lung 
at later timepoints [101]. Although showing limited effects in mice, these results 
are confounded by the redundancy of these cytotoxic pathways, and perhaps by 
the increased IFNγ in these KO mice [98].  
Granulysin is another important cytotoxic granule expressed by human and 
NHP CD8 T and NK cells. Granulysin has been shown to directly lyse extracellular 
Mtb and kill intracellular Mtb through a perforin dependent mechanism [73]. 
Because of the lack of granulysin gene ortholog in rodents, NHP may provide a 
better experimental model for accessing cytotoxic function of CD8 T cells. Recently, 
Gideon and Hughes tried to define protective cellular responses in cynomolgus 
macaques by comparing the cellular component in restrictive vs. permissive 
granulomas using scRNA-seq [80]. They found granulomas with greater Mtb 
control were enriched with cytotoxic CD8 T cells. Cytotoxic CD8 T cells expressing  
granzyme B, perforin, and granulysin are also found in human leprosy, an infection 
caused by Mycobacterium leprae [75]. Interestingly, these CD8 T cells express 
various NK receptors that are typically found on NK cells [75].  
Despite this challenge to prove the importance of a specific effector function, 
it reflects the complexity of mechanisms CD8 T cells used to confer protection. 
Both cytokine and cytotoxic dependent functions can be involved. The 
mechanisms CD8 T cells used to mediate protection in vivo still needs to be 
elucidated.  
CD8 T cells recognition of infected cells 
With the effector functions mentioned above, we would expect CD8 T cell 
target infected cells in lungs that presented Mtb peptides on the MHCI molecules. 
This occurs via the cognate recognition of peptide-MHCI by the TCR on CD8 T 
cells. However, CD8 T cells don’t always recognize infected cells. In our study led 
by Jason Yang, we showed CD8 T cells specific for the  immunodominant epitope, 
TB10.44-11 didn’t efficiently recognize Mtb infected macrophages [102]. TB10.4 is 
encoded by gene esxH.  After Mtb infection, 30-50% of pulmonary CD8 T cells in 
C57BL/6J mice are specific for TB10.44-11. Why TB10.44-11 specific CD8 T cell 
responses are so immunodominant is not clear. Immunodominance describes a 
phenomenon that despite thousands of peptides generated from pathogen 
associated antigens during infections, only a few of the trimmed peptides can be 
loaded on MHCI or II molecules by APCs, and presented to CD8 and CD4 T cells, 
respectively. In addition, the dominant T cells can actively suppress the 
subdominant T cells, in part through competing for APCs; a process called 
immunodomination. Immunodominant Mtb antigens are often used in TB diagnosis 
tests, and are included as components for TB vaccines.  
In our study, the ability of TB10.44-11 specific CD8 T cells to recognize 
infected macrophages, measured by Nur77 upregulation and IFNγ secretion, were 
compared to Ag85b specific CD4 T cells. TB10.44-11 specific CD8 T cells were less 
efficient in recognizing infected macrophages, and failed to control Mtb growth in 
macrophages. In contrast, Ag85b specific CD4 T cells effectively recognized 
infected cells and inhibited intracellular Mtb growth [102]. This provided a potential 
mechanism by which vaccines eliciting immunodominant CD8 T cell responses fail 
to confer protection [36]. This result is consistent  with a previous finding that CD8 
T cells derived from recipients of an adenoviral vector vaccine, AERAS-402 didn’t 
recognize infected cells [103]. The discrepancy between  the overwhelming  
TB10.44-11 specific CD8 T cell responses generated in vivo, but the failure of these 
cells to restrict Mtb growth because of inefficient recognition raises a possibility: 
whether Mtb actively drives the immunodominant response as a strategy to evade 
immune surveillance by CD8 T cells. This theory may be supported by the 
evolutionary conserve of Mtb genes that contained T cell epitopes [104, 105]. We 
therefore hypothesized that TB10.4 is a “decoy antigen” and the 
immunodominance of TB10.44-11 specific CD8 T cells were generated by Mtb for 
its fitness.  
To test this decoy hypothesis, a study led by Rujapak Sutiwisesak in our lab 
leveraged a naturally occurring polymorphism in TB10.44-11 epitope, esxHA10T [106]. 
An isogenic strain of Erdman that expressed esxHA10T epitope was generated. 
They found polymorphism EsxHA10T altered immune hierarchy of CD8 T cells. The 
frequency of TB10.44-11 specific CD8 T cells was decreased, but the frequency of 
subdominant Mtb32A309-318 specific CD8 T cells was increased. Moreover, the 
abilities of Erd.EsxHWT and Erd.EsxHA10T elicited CD8 T cells to recognize infected 
macrophages were tested. For this purpose, the Mtb-infected macrophages 
ELISPOT (MIME) assay was developed by Yash Patankar and colleagues [107]. 
Purified CD8 T cells from Erd.EsxHWT or Erd.EsxHA10T infected mice were cultured 
with infected macrophages, and the frequency of CD8 T cells recognizing infected 
macrophages were calculated by the spots developed in IFNγ ELISPOT. They 
found Erd.EsxHA10T elicited CD8 T cell recognized infected macrophages 
differently. This result indicates immune hierarchy is altered when the 
immunodominant response is disrupted, and supports the hypothesis that a non-
protective dominant response suppressed subdominant responses [106].   
Despite TB10.44-11 specific CD8 T cells not  recognizing infected 
macrophages, there are some pulmonary CD8 T cells from a polyclonal pool that 
can recognize infected macrophages [107]. This recognition of infected cells by 
polyclonal CD8 T cells has been indirectly studied for years when CD8 T cells 
derived from Mtb infected experimental animals and/or TB patients were assayed 
for their cytotoxic functions. Interestingly, when T cells were cultured with infected 
cells that have different multiplicity of infection (MOI), CD8 T cells responded better 
to infected cells with high MOI, while CD4 T cells can respond to infected cells with 
low MOI and the responses plateau at high MOI. This result that CD8 T cells 
preferentially recognized heavily infected cells was also observed by Lewinsohn 
and colleagues [108]. Direction for future studies includes the identification of 
antigens presented on infected cells that can be recognized by CD8 T cells, and 
to test whether vaccines that contain these antigens confer better protection.  
 
A Lesson from Other Infectious Diseases and Tumor: CD4 T Cells are 
Required for Optimal CD8 T cell Responses 
 
Helped vs. helpless CD8 T cells 
Through antibody mediated depletion, adoptive transfer, and genetic KO 
mice, CD8 T cells’ role in immunity to Mtb was assessed in murine models. Despite 
being recognized as an integral part of immunity, the relative contribution of CD8 
T cells has been questioned. However, the approaches mentioned above only 
examined CD8 T cells as an independent cell subset, and can’t assess the synergy 
between CD4 and CD8 T cells. CD4 T cells are essential for optimal CD8 
responses in many viral infections and cancer, which is called CD4 T cell help. 
CD8 T cell function is likely compromised without CD4 T cell help.  
The importance of CD4 T cell help was first established in generation of 
functional CD8 T cell memory responses following both immunization and primary 
infection. The lack of CD4 T cell help results in memory responses that are 
defective in magnitude and function [109-111]. Despite most studies reporting  the 
effective memory responses were “programmed” during CD8 T cell priming [109, 
110, 112], one study demonstrated the need of CD4 T cell help to maintain, in 
addition to generate, the effective memory responses [113]. Moreover, it’s known 
that inflammation and antigen load play key roles for the generation of memory 
CD8 T cells, and CD4 T cells regulate this process [114-116]. For example, 
helpless CD8 T cells have increased T-bet expression [115], which could 
compromise memory formation. Treg cells also modulate in this process through 
the production of IL-10 [117, 118].  
The role of CD4 T cell help in primary infection is more controversial. In 
some studies, the magnitude and function of CD8 T cell responses were 
comparable with or without CD4 T cells, while other studies showed defective CD8 
T cell responses in the absence of CD4 T cells. The fact that innate signals can 
activate APCs in addition to CD4 T cells reconciles the conflicts [119]. Thus, CD4 
T cell help is more crucial in immunizations or infections in which type I IFN 
production is modest. In contrast, CD4 T cell help is bypassed in infections when 
strong inflammation is induced. The conflicting results from the same pathogens 
may also reflect the difference in dose and virulence of inoculums. However, CD4 
T cells are shown to be crucial to maintain CD8 T cell function in chronic viral 
infections. Without CD4 T cells, CD8 T cells lose antiviral function, resulting in 
uncontrolled infection [120-124]. Moreover, IL-21 secreted by CD4 T cells are 
associated with supporting CD8 T cell function in chronic infections [125-127].  
As mentioned above, whether CD8 T cell effector functions during primary 
infection depend on CD4 T cell help needs to be clarified. Recently, RNA-seq and 
scRNA-seq have used to assess the impact of CD4 T cell help on CD8 T cell 
transcriptional profiles, suggesting a global impact on CD8 T effector cells. Using 
both vaccine and acute LCMV infection models, Ahrends and colleagues 
uncovered that CD4 T cell help turned on transcriptional networks of CD8 T cells, 
promoting both effector and memory CD8 T cell formation [128]. Moreover, helped 
CD8 T cells had greater migratory potential through upregulating chemokine 
receptors. In another study, Zander and colleagues identified a CD4 help- and IL-
21-dependent subset of CD8 T cells in chronic LCMV infection using scRNA-seq, 
and they showed this subset had cytotoxic function [129].  
T cell exhaustion are associated with the lack of CD4 T cell help. The loss 
of antiviral function on helpless CD8 T cell during chronic virus infection implies 
these CD8 T cells may be exhausted, though the term “T cell exhaustion” was not 
used in these early studies [121, 124]. Nevertheless, recent studies showed 
helpless CD8 T cells expressed multiple inhibitory receptors, and through 
transcriptional analysis, helpless CD8 T cells have been shown to have features 
resembling exhausted T cells [128, 130, 131]. In summary, CD4 T cell help is 
indispensable in many aspects of the CD8 T cell response.  
Molecular nature of CD4 T cell help 
Considerable studies address the molecular mechanisms of how CD4 T 
cells provide help to CD8 T cells. CD4 and CD8 T cells differ in the ways they are 
activated. CD8 T cells recognize intracellular antigens that are processed by the 
proteasome and presented on MHC I molecules, while CD4 T cells recognize 
antigens that entered the endocytic pathway and are loaded on the MHC II 
molecules after degradation  in the phagosome. Thus, the antigen presenting cells 
(APC) that have both MHC I and II molecules, and are efficient in “cross-
presentation” (loading the endocytic antigens on MHC I molecules) become the 
bridge to connect the CD4 and CD8 T cell immunity against pathogens. The “help” 
signals from CD4 T cells are also delivered through this bridge. It’s shown that 
XCR1+ DCs are the platform that relay  the “help” to CD8 T cells [132, 133]. XCR1+ 
DCs are “licensed” when they received signals through CD40 that are engaged  
with CD40L on activated CD4 T cells [134, 135]. The activating signals, combined 
with innate signals XCR1+ DCs received through pattern recognition receptors, 
upregulate the expression of MHC molecules and co-stimulatory receptor CD70 
and CD80/86, which interacts with CD27 and CD28 on CD8 T cells, respectively. 
Activated XCR1+ DCs also produce more cytokines, including IL-12, IL-15, and 
Type 1 IFN. These cytokines and co-stimulatory signals then integrate as an output 
that XCR1+ DCs present  to CD8 T cells, dictating their differentiation and effector 
functions. In addition, IL-2 and IL-21 produced by CD4 T cells are also reported to 
be help signals that CD4 T cells directly deliver to CD8 T cells without DCs. 
For several years, scientists were puzzled by the low likelihood that CD4 
and CD8 T cells specific for same antigen were cognate engaged with the same 
DCs. Recently, two groups answered this question by a two-step priming model 
using intravital 2-photon microscopy [132, 133]. In this model, CD4 and CD8 T 
cells are first activated by different subsets of migratory DCs in separate locations. 
The activated CD8 T cells then secrete XCL1 to recruit XCR1+ resident DCs. 
Finally, XCR1+ DCs migrate deeper into the paracortical area of lymph nodes, 
where they cognate engage with pre-activated CD4 and CD8 T cells and relay help 
to pre-activated CD8 T cells.  
  
CD4 T cell Help during Tuberculosis 
 
How CD4 T cell help shapes CD8 T cell responses during Mtb infection is 
not fully elucidated. Nevertheless, a few studies suggest CD8 T cells’ effector 
functions may depend on CD4 T cells. Serbina and colleagues first showed CD8 
T cells from infected CD4 KO mice had impaired ability to lyse target cells in vitro 
[136]. However, this result was compromised by later studies reported that CD4 
KO mice have MHCII restricted T cells [137, 138]. The ability to produce IFNγ by 
CD8 T cells in the absence of CD4 T cells was addressed, but conflicting results 
were generated. Two studies showed that IFNγ production by CD8 T cells depend 
on CD4 T cells. Using direct intracellular staining without in vitro stimulation, Bold 
and colleagues found that in lungs of infected mice, the frequency of IFN+ CD8 T 
cells correlated with the frequency of IFN+ CD4 T cells, and the percentage of IFN+ 
CD8 T cells was decreased in mice following antibody mediated depletion of  CD4 
T cells [85]. In addition, Green and colleagues showed impaired CD8 responses, 
including IFNγ production, in the absence of CD4 T cells in a model where RAG 
KO mice were reconstituted with splenocytes  that were depleted or non-depleted 
of CD4 T cells [87]. In contrast, Carusa and colleagues reported IFNγ produced by 
CD8 T cells was only transiently diminished in the absence of CD4 T cells [86].  
As discussed previously, several pathways have shown to play roles in CD4 
T cells providing help to CD8 T cells during viral infection. Deficiency in these 
signalings during Mtb infection leads to impaired CD8 T cell responses, which 
implies CD4 T cells play an essential role in effective CD8 T cell responses. Booty 
and Barreira-Silva et al showed impaired priming in lymph nodes and accumulation 
in lungs of TB10.44-11 specific IL-21R KO CD8 T cells, with experiments in which 
TB10.44-11 specific IL-21R KO or competent CD8 T cells were co-transferred into 
infected C57BL/6 mice [139]. CD8 T cells from IL-21R KO mice had decreased 
cytokine production, but increased inhibitory receptor expression compared to 
CD8 T cells from WT mice [139]. Moreover, compromised primary and secondary 
CD8 T cell responses in IL-15 KO mice are also reported [140, 141]. Interestingly, 
while Lazarevic and colleagues reported the limited role of IL-15 signaling in 
generating effective primary CD8 T responses, compared to its significant role in 
recall responses [140], Rausch and colleagues found impaired expansion, 
proliferation, and effector functions of CD8 T cells from IL-15 KO mice in primary 
Mtb infection [141]. Overall, Mtb specific CD8 T cell responses in the quality and 
quantity of Mtb specific CD8 T cell responses in the presence or absence of CD4 
T cell help needs further investigation to resolve the conflicts.     
Whether helped CD8 T cells mediate enhanced protection is unknown. This 
question is challenging to address because it requires the dissociation of CD4 T 
cells’ role as regulatory cells from the direct protection they mediate. In the study 
mentioned above, Booty and Barreira-Silva et al indirectly studied this question 
[139]. They showed IL-21R KO T cells mediated less protection when adoptively 
transferred into TCRα KO mice before challenge, while purified CD4 T cells from 
WT or IL-21R KO mice conferred comparable protection. However, they failed to 
show the protection mediated by WT or IL-21R KO CD8 T cells because an 
unexpected wasting syndrome developed in TCRα KO mice infused with IL-21R 
KO CD8 T cells. This study may imply that “helpless” CD8 T cell responses 
contribute to the susceptibility of IL-21R KO mice, but further studies are needed 
to be conclusive. Thus, whether CD4 T cell help is essential to protective CD8 T 




A better understanding of how different elements of our immune system 
collaborate to fight Mtb is the foundation for developing effective vaccines. The 
relative contribution of CD8 T cells in immunity to TB is contested mainly because 
of previous findings in murine models. In light of emerging data implying the 
essential role of CD8 T cells, we argue CD8 T cells are an important arm in 
protective immunity and their role needs further investigation. Recent studies focus 
on the immunodominant CD8 T cells, and the possibility that Mtb exploits 
immunodominance to evade immune surveillance. However, some CD8 T cells 
can recognize infected cells. To better understand protective CD8 T cell responses, 
this dissertation focuses on whether CD4 T cell help is involved in shaping CD8 T 
cell responses, and the molecular mechanisms of such CD4 T cell help. More 
importantly, I address whether helped CD8 T cells mediate better protection 
against Mtb.  
Using a series of unbiased approaches, we uncover the “helped” vs. 
“helpless” CD8 T cell features in chapter II. In this chapter, we also address 
whether helped CD8 T cells are more protective through both in vitro and in vivo 
methods. Furthermore, how the CD4 T cell help delivers to CD8 T cells is 
addressed in chapter III. The requirements of several pathways in shaping 
effective CD8 T cells responses are determined. I then report an unexpected role 
of MHCII molecules in regulating CD8 T cells’ behavior in chapter IV. Finally, I 
discuss how this current dissertation broadens our knowledge of the role CD8 T 
cells play in immunity to Mtb, focusing on the impact of CD4 T cell help, the new 
findings of CD8 T cell in NHP models, and the implication on vaccine design. The 
data presented in this dissertation will enhance our understanding of protective 
immune responses in TB, and provide insights to vaccine development.   
CHAPTER II. CD4 T CELL HELP PREVENTS CD8 T CELL 
EXHUASTION AND PROMOTES CONTROL OF 
MYCOBACTERIUM TUBERCULOSIS INFECTION 
 
Yu-Jung Lu1,2, Palmira Barreira-Silva3,4, Shayla Boyce2, Jennifer Powers2, Kelly 
Cavallo2, Samuel M. Behar1,2* 
 
1. Immunology and Microbiology Program, Graduate School of Biomedical Science, 
University of Massachusetts Medical School, Worcester, Massachusetts, USA. 
2. Department of Microbiology and Physiological Systems, University of 
Massachusetts Medical School, Worcester, Massachusetts, USA. 
3. Life and Health Sciences Research Institute (ICVS), School of Medicine, 
University of Minho, Braga, Portugal. 
4. ICVS/3B’s, PT Government Associate Laboratory, Braga/Guimarães, Portugal. 
 




Conceptualization, Y.L. and S.M.B.; Methodology, Y.L., P.B.S., and S.M.B.; Investigation, 
Y.L., P.B.S., S.B., J.P., and K.C.; Formal analysis, Y.L. and S.M.B.; Writing- Original Draft, 
Y.L.; Writing- Review & Editing, Y.L., P.B.S., S.B., J.P., K.C., and S.M.B.; Supervision, 
S.M.B.; Funding Acquisition, S.M.B.  
Abstract 
 
CD4 T cells are essential for immunity to tuberculosis because they produce 
cytokines including interferon-γ. Whether CD4 T cells act as “helper” cells to 
promote optimal CD8 T cell responses during Mycobacterium tuberculosis is 
unknown. Using two independent models, we show that CD4 T cell help enhances 
CD8 effector functions and prevents CD8 T cell exhaustion. We demonstrate 
synergy between CD4 and CD8 T cells in promoting the survival of infected mice. 
Purified helped, but not helpless, CD8 T cells efficiently restrict intracellular 
bacterial growth in vitro. Thus, CD4 T cell help plays an essential role in generating 
protective CD8 T cell responses against M. tuberculosis infection in vitro and in 
vivo. We infer that vaccines which elicit both CD4 and CD8 T cells are more likely 




Tuberculosis (TB) is a serious global health issue. BCG is the only approved 
TB vaccine and despite achieving clinically significant protection in infants and 
toddlers, it has variable efficacy against pulmonary disease, which is the form of 
disease that leads to transmission [8]. More effective vaccines are required to stop 
transmission and reduce global TB burden. To develop more effective vaccines, 
we need a better understanding of how Mycobacterium tuberculosis (Mtb) evades 
immunity and how the different elements of our immune system interact to contain 
and eliminate Mtb infection.  
T cells are required for containment of primary Mtb infection and most TB 
vaccines in development elicit T cell responses [13, 61, 142]. While Mtb infection 
elicits both CD4 and CD8 T cells, the increased risk of TB in HIV-infected persons 
highlights a crucial role for CD4 T cells [69-71, 143]. The essential role for CD4 T 
cells in immunity to Mtb is supported experimentally by the early mortality of mice 
lacking CD4 T cells [24]. While mice lacking CD8 T cells also die prematurely after 
Mtb infection, they survive longer than mice without CD4 T cells, which has led to 
the conclusion that CD4 T cells are more important for protection than CD8 T cells 
[24]. The inability of CD8 T cells to transfer significant protection to 
immunodeficient mice supports this assertion [144]. However, there are other 
interpretations of these data. For example, studies on people with AIDS have 
demonstrated the importance of CD4 T cells in regulating virtually every arm of the 
immune response. The contribution of CD4 T cells in generating optimal CD8 T 
cell and B cell responses is called CD4 T cell help. We hypothesize that CD8 T 
cells require CD4 T cell help to develop into effector CD8 T cells capable of 
controlling Mtb infection. 
CD4 T cell help enables CD8 T cells to respond more efficiently to viruses 
and cancer [68]. CD4 T cells promote CD8 T cell expression of effector molecules 
such as IFNγ, TNF, granzyme A and B, and facilitate greater migration of CD8 T 
cells by upregulating several chemokine receptors [128]. The development of 
CX3CR1+ CD8 T cells, noted for their cytolytic function, requires CD4 T cell help 
[129]. Helped CD8 T cells express transcriptional networks that promote effector 
and memory cell development [128]. Indeed, CD4 T cell help during CD8 T cell 
priming promotes memory development and imprints a quick effector recall 
response upon challenge [109-112]. In contrast, helpless CD8 T cells upregulate 
inhibitory receptors characteristic of exhausted CD8 T cells [128]. 
If CD4 T cells mediate both effector and regulatory functions during TB, the 
question arises whether the lack of CD4 T cell help compromises CD8 T cell 
responses and contributes to the susceptibility of CD4 T cell deficient mice. This is 
a difficult hypothesis to test as it requires dissociating the effector and regulatory 
functions of CD4 T cells. Nevertheless, other studies have addressed how CD4 T 
cells affect CD8 T cell immunity during TB. CD8 T cell priming and recruitment to 
the lung occurs in CD4-deficient mice, although the quantity and quality of Mtb-
specific CD8 T cells elicited without CD4 T cells hasn’t been assessed [86, 136]. 
During TB, CD4 T cell help promotes CD8 T cell IFNγ production and cytolytic 
activity, but whether helped CD8 T cells mediate greater protection is unknown [85, 
87, 136]. To answer these questions, we compared CD8 T cell responses in 
infected WT or MHCII KO mice and confirmed our results in a novel adoptive 
transfer model in which purified CD8 T cells from uninfected mice were transferred 
with or without Ag85b-specific CD4 T cells into TCRα knockout (KO) mice. We 
found that helped and helpless Mtb-specific CD8 T cell responses differed in 
effector molecule and coinhibitory receptor expressions. Importantly, we found that 
helped CD8 T cells mediate better Mtb control than helpless CD8 T cells, leading 
us to predict that vaccines that elicit both CD4 and CD8 T cell responses are likely 
to confer the greatest protection.   
Results 
Mtb-specific CD8 T cell responses are generated independently of CD4 T 
cells 
MHCII KO mice were used to study the CD8 T cell response to Mtb in the 
absence of CD4 T cell help. The “helpless” CD8 T cells (i.e., from MHCII KO mice) 
were compared to “helped” CD8 T cells from Mtb-infected C57BL/6 mice (hereafter, 
WT). MHCII KO mice had significantly higher bacterial burden in lungs and spleens 
(Figure 2.1 A right) and succumbed early after infection as previously described 
(Figure 2.1 A left) [24]. To determine whether CD4 T cell help is required to 
generate CD8 T cell responses in the lung, we measured Mtb-specific CD8 T cell 
responses for two dominant epitopes, TB10.44-11 and 32A309-318 [106, 145]. These 
CD8 T cell responses were elicited by Mtb infection without apparent delay in the 
absence of CD4 T cells (Figure 2.1 B).  The frequencies and absolute numbers of 
TB10.44-11 specific CD8 T cells were higher in MHCII KO than WT mice early during 
infection, which may have been driven by the greater bacterial load in MHCII KO 
mice (Figure 2.1 B,C). CD8 T cells differentiate into KLRG1+CD127- short-lived 
effector cells (SLEC) or KLRG1-CD127+ memory precursor cells (MPEC) upon 
activation. The frequencies of SLEC and MPEC CD8 T cells in the lung of WT and 
MHCII KO mice were similar. However, the frequencies of both SLEC and MPEC 
TB10.44-11 -specific CD8 T cells were greater in WT mice than in MHCII KO mice 
(Figure 2.1 D,E). These results indicate that CD8 T cell responses to Mtb are 
generated independently of CD4 T cell help. However, CD4 T cells promote the 
differentiation of CD8 T cells into SLEC and MPEC cells, consistent with results 





























































































































































Figure 2. 1 Mtb-specific CD8 T cell responses are generated in MHCII KO 
mice.  
(A) Left, cumulative survivals of WT and MHCII KO mice after infection with 
aerosolized Mtb. Data were compiled from 9 experiments with 56 WT and 57 
MHCII KO mice. The black ticks represent censored subjects (56 WT and 48 
MHCII KO mice) that were analyzed at defined time points. The difference between 
the strains was statistically significant (p=0.0002) as determined by the log-rank 
test. Right, bacterial burden in lungs and spleens of WT and MHCII KO mice were 
determined at 8 weeks post infection (wpi). Data are representative of two 
independent experiments, 5 mice/group. Bars, mean ± SD. (B-C) Lung cells from 
WT and MHCII KO mice were analyzed at 4, 5, and 8 wpi to determine the 
frequencies of TB10.44-11 and 32A309-318 -specific CD8 T cells and the number of 
TB10.44-11 specific CD8 T cells. The frequencies of KLRG1+CD127- (SLEC) and 
KLRG1-CD127+ (MPEC) among total CD8 T cells and TB10.44-11 -specific CD8 T 
cells was determined 8 wpi by flow cytometry (D, representative data) and 
analyzed statistically (E). (B, C, E) Representative data of three independent 
experiments, 4-5 mice/group. Data represent mean ± SD. Statistical significance 
was analyzed by multiple t test (B, C) or unpaired t test (A, E). p-values: *, p<0.01; 




Helped vs helpless CD8 T cells: transcriptional signatures of cytotoxic vs. 
exhausted CD8 T cells 
To comprehensively identify differences between “helped” and “helpless” 
CD8 T cells, we purified lung CD8 T cells from WT or MHCII KO mice 8 weeks 
post infection (wpi) and performed RNA-seq. We found 1,072 genes differed in 
their expression between WT and KO CD8 T cells (padj<0.05 and |log2 fold-
change|³1). Among these genes, 173 were upregulated in WT cells, while 899 
genes were upregulated in KO cells (Figure 2.2 A). Among the genes upregulated 
in WT cells, MHCII molecules were the ones with the largest fold changes. 
Enrichment analysis using Gene Ontology (GO) terms revealed WT CD8 T cells 
expressed pathways involved in IFNγ production and cell killing (Figure 2.2 B). 
These data show that IFNγ production and cytotoxicity by CD8 T cells is 
augmented by CD4 T cells during Mtb infection. Gene sets associated with NK cell 
immunity were detected in the enrichment analysis, including expression of NK 
receptors Klrk1 (NKG2D) and CD244 (2B4) (Figure 2.2 B, C). These receptors are 
associated with secretion of multiple cytotoxic granules, indicating enhanced 
cytotoxicity of helped CD8 T cells [75]. Since the RNA-seq analysis was performed 
using total lung CD8 T cells, which contain approximately 50% intravascular cells 
and could dilute the signal attributable to Mtb-specific CD8 T cells, we changed the 
criteria to “padj <0.05” without restrictions on fold-change. More genes associated 
with an effector state were identified as upregulated in WT cells including 
transcription factors that drive effector CD8 T cell differentiation (e.g., Tbx21, Zeb2, 
and Id2), activation markers (e.g., Il2ra, CD69, and Itgal), and cytotoxic molecules 
(e.g., Gzma and Gzmb) (Figure 2.2 C).  
Gene set enrichment analysis (GSEA) found that the MHCII KO CD8 T cells 
upregulated genes associated with T cell exhaustion and were enriched for genes 
from the signature of CD8 T cells from mice with chronic LCMV infection [146] 
(Figure 2.2 D, top row). Genes upregulated in KO cells were enriched in genes 
differentially expressed by exhausted cells compared to effector or memory CD8 
T cells (Figure 2.2 D, top row). Indeed, MHCII KO CD8 T cells upregulated many 
genes encoding inhibitory receptors, including Pdcd1(PD-1), Havcr2 (Tim-3), Lag3, 
and Entpd1 (CD39) (Figure 2.2 C). Transcription factors Eomes, c-Maf, and Tox 
were all upregulated in MHCII KO CD8 T cells (Figure 2.2 C). In contrast, WT CD8 
T cells upregulated genes from the effector and memory signatures (Figure 2.2 D, 
bottom row). Thus, helped WT CD8 T cells express an effector transcriptional 
program that is remarkable for greater expression of molecules associated with 
cytotoxicity including TNF, granzyme A and B, and NK receptors. In contrast, 
helpless MHCII KO CD8 T cells have an exhaustion signature including PD-1, Tim-
3, Tox, CD39 and Lag-3. 
 
  
Figure 2. 2 Transcriptional features of WT vs. MHCII KO CD8 T cells.  
(A) Volcano plot of transcriptome comparison. Transcripts of purified MHCII KO 
CD8 T cells were compared to WT CD8 T cells from Mtb-infected mice 8 wpi. Blue 
dots indicate differentially expressed genes (p-adjusted value <0.05 and |log2 fold 
change|³1). (B) Gene Ontology analysis for genes significantly upregulated in WT 
CD8 T cells. Bubble plot presents top 10 pathways that were most significantly 
enriched. (C) Heatmap displaying differentially expressed genes in each category. 
Color indicates row z scores. (D) GSEA. Data were compared to published 
datasets available at Gene Expression Omnibus (GEO): GSE30962 and GSE9650. 
NES, normalized enrichment score. FDR, false discovery rate. 
 
  
Helped vs helpless CD8 T cells: cytotoxic vs. exhausted CD8 T cells 
To validate the transcriptional signatures, we performed single cell analysis 
of CD8 T cells from infected WT or MHCII KO mice using 19-parameter flow 
cytometry. Since cells located in lung parenchyma are more likely to interact with 
infected cells, an established approach was used to distinguish intravascular from 
parenchymal CD8 T cells [147, 148]. More parenchymal WT CD8 T cells 
expressed NK receptors including NKG2D and 2B4 than parenchymal MHCII KO 
CD8 T cells. In contrast, MHCII KO CD8 T cells expressed significantly more co-
inhibitory receptors, including PD-1, Tim-3, Lag-3, and CD39, typical of exhausted 
CD8 T cells (Figure 2.3 A). Differences in transcription factor expression were 
consistent with our RNA-seq analysis, with a dramatic increase in Eomes 
expression by MHCII KO CD8 T cells (Figure 2.3 B). WT CD8 T cells expressed 
higher levels of T-bet and Tcf-1. These differences between WT and MHCII KO 
CD8 T cells were also identified in total lung CD8 T cells (Figure 2.3 C,D). 
To facilitate the flow cytometric analysis, UMAP projections were created to 
visualize differences between the WT and MHCII KO CD8 T cells during Mtb 
infection (https://arxiv.org/abs/1802.03426). Intravascular and parenchymal CD8 
T cells were easily distinguished in the UMAP projection (Figure 2.3 E). In the lung 
parenchyma, most CD8 T cells were antigen-experienced (CD44+), but a minor 
population of naïve cells (CD62LhiCD44lo) was also identified. The majority of 
MHCII KO CD8 T cells localized to the lung parenchyma, perhaps driven by the 
higher bacterial burden in MHCII KO mice (Figure 2.3 E, F). 
Antigen-experienced (CD44+CD62L-) lung parenchymal WT and MHCII KO 
CD8 T cells were clustered into eight distinct populations on the UMAP projection 
using PhenoGraph™[149] (Figure 2.3 H, I). Clusters A-D were dominated by WT 
CD8 T cells (Figure 2.3 J), which were T-bet+Slamf7+PD1lo, suggesting an effector 
state [150-152]. Cells in cluster A expressed Klrg1, Tcf1, and Eomes. While Tcf1 
and Eomes can regulate the generation of memory and exhausted T cells, both 
populations arise from Klrg1- populations [146, 153]. Thus, Cluster A may 
represent cells in transition. Cluster B and C expressed T-bet and Slamf7, which 
defined these as effector cells. Cluster B are terminal effector cells based on their 
KLRG1 expression. As both KLRG1+ and KLRG1- populations expressed NKG2D, 
NKG2A/C/E, and 2B4, cluster B and C might vary in their differentiation states 
rather than having distinct effector functions (Figure 2.3 G). Cluster D expressed 
Tcf1, Eomes, and CD127, consistent with memory precursor cells (see Figure 1, 
MPECs) [154].  
Clusters E-H were predominantly MHCII KO CD8 T cells and were 
distinguished by their expression of PD-1 (Figure 2.3 H-J). The PD-
1lowTCF1+Eomeslow phenotype of cluster E was typical of exhausted progenitor 
CD8 T cells, while cluster H appeared to be terminally exhausted CD8 T cells 
based on expression of the inhibitory receptors Tim-3, Lag-3, and CD39, and the 
transcription factors Eomes and c-Maf. Cluster F and G likely represent exhausted 
states as well, since both expressed high PD-1 levels and Eomes. Cluster F didn’t 
express as many inhibitory receptors as cluster H, and cluster G was the only 
cluster that expressed KLRG1 and T-bet among clusters E-H. Recent studies 
suggest CD8 T cells with an effector-like profile can represent a transition state 
before terminal exhaustion [155]. Similarly, KLRG1 is expressed on partially 
exhausted cells [156, 157]. In summary, we extend the results of our RNA-seq 
analysis by showing that helped WT CD8 T cells included subsets of cells that 
were effector cells with cytotoxic features. In contrast, helpless MHCII KO CD8 T 





Figure 2. 3 WT CD8 T cells are cytotoxic effectors, while MHCII KO CD8 T 
cells are exhausted cells.   
WT and MHCII KO mice were infected with aerosolized Mtb for 8 weeks. (A-B) 
Anti-CD45-AF647 was injected intravenously 3 minutes before euthanasia. (A) 
Lung parenchymal (CD45iv-CD44+CD62L-) CD8 T cells were analyzed by flow 
cytometry to determine the frequencies of NK and inhibitory receptors. The mean 
% ± SD for each quadrant is indicated (n=5/group). The percentage of WT vs. KO 
cells in each quadrant was compared, and if statistically significant, is indicated in 
the WT quadrant. (B) The median fluorescence intensity (MFI) or average 
percentage of cells expressing each transcription factors, ± SD, are indicated. (C-
D) Total lung CD8 T cells were analyzed by flow cytometry to determine the 
percentage of NK and inhibitory receptors, and the median fluorescence intensity 
(MFI) or average percentage of cells expressing each transcription factors. The 
mean % ± SD are indicated (n=5/group). UMAP projections from the flow 
cytometric analysis of lung total CD8 T cells (E) or parenchymal CD8 T cells (H) 
were overlayed with expression of the indicated markers. (F) Frequencies of CD8 
T cells located in parenchyma were analyzed statistically. Bar, mean. (G) 
Frequencies of KLRG1 and NKG2D, NKG2A/C/E, or 2B4 in lung parenchymal 
(CD45iv-CD44+CD62L-) CD8 T cells were determined. (I-J) Eight clusters were 
identified using PhenoGraph and the percentage of each cluster among WT or 
MHCII KO lung parenchymal CD8 T cells were analyzed statistically. Bars, mean 
± SD. (A-I) Representative data of two independent experiments, 5 mice/group. 
Statistical significance was analyzed by two-way ANOVA (A, C, J) or unpaired t 
test (B, D, F). p-values: **, p<0.01; ***, p<0.001; ****, p<0.0001; #, p<0.0001. ns, 
no significant differences. 
  
Validation of the “helped” and “helpless” CD8 T cell states using an 
independent model 
We considered whether a developmental or intrinsic defect in MHCII KO 
CD8 T cells could explain the differences we observed between “helped” and 
“helpless” CD8 T cells. We analyzed splenic CD8 T cells from uninfected WT and 
MHCII KO mice and found higher expression of Lag-3 and PD-1 on MHCII KO CD8 
T cells. (Figure 2.4 A-C). Although these coinhibitory receptors were expressed at 
very low frequencies of CD8 T cells from uninfected mice compared to cells from 
the lungs of infected mice, it indicated that MHCII KO CD8 T cells differ from WT 
CD8 T cells [158].  Therefore, we developed an independent model to validate our 
findings. Purified splenic CD8 T cells from naïve C57BL/6J mice were transferred 
into TCRα KO recipients with or without CD4 T cells. As CD4 T cells can transfer 
protection, which would be a potential confounder, we sought to minimize their 
contribution to protection by using CD4 T cells from the P25 TCRtg mouse. P25 
TCRtg CD4 T cells (hereafter, P25 cells) are specific for Ag85b, a protein that is 
downregulated by Mtb within weeks of infection [159, 160]. The ability of P25 cells 
to transfer protection was largely independent of their number. By restricting the 
diversity and number of transferred CD4 T cells, and selecting an antigen that is 
transiently expressed, we hoped to limit the impact of CD4 T cells on protection 
while still providing CD4 T cell help. TCRα KO mice received 5 million CD8 T cells 
and 100,000 P25 cells (hereafter, helped mice) or only 5 million CD8 T cells 
(hereafter, helpless mice).  
We compared the survival of helped and helpless mice to recipient TCRα 
KO mice that received only P25 cells or no cells after Mtb infection (Figure 2.5 A). 
TCRα KO mice have a median survival time (MST) of 39 days. Helpless mice (CD8 
T cells only) have a MST of 46 days, which shows that CD8 T cells alone conferred 
little protection. TCRα KO mice that only received P25 cells survived 88 days 
(MST). In contrast, helped mice survived 136 days (MST). We determined whether 
P25 and CD8 T cells synergized to promote survival using the statistical models 
developed by Demidenko and Miller and based on the Bliss definition of drug 
independence [161]. The additive effect of P25 and CD8 T cells on survival (i.e., 
independent effect) can be calculated as 1 – (1-SA(t))x(1-SB(t)), where SA(t) and 
SB(t) are the survival curves of mice received P25 and CD8 T cells, respectively. 
The curve generated by this function largely overlaps with the survival curve of 
mice received P25 cells, indicating that CD8 T cells by themselves, contribute little 
to the overall survival (Figure 2.5 B). The actual survival curve of helped mice is 
significantly greater than their predicted independent effects, establishing synergy 
between P25 and CD8 T cells (Figure 2.5 B). We infer that the prolonged survival 
of mice that received both polyclonal CD8 T cells and P25 cells arose from the 
action of helped CD8 T cells.  
Like the MHCII KO mice, antigen-specific CD8 T cell responses (TB10.4+) 
were generated in both helped and helpless mice (Figure 2.5 C). Very few 32A309-
318 -specific CD8 T cells were detected. The frequency of TB10.44-11 -specific CD8 
T cells was comparable between helped and helpless mice. More CD8 T cells 
differentiated into SLECs in helped than in helpless mice at 7 wpi (Figure 2.5 D, 
E). In contrast, the MPEC frequencies were similar. Thus, this transfer model 
shows that CD8 responses to Mtb could be generated in the absence of CD4 T 
cells, but CD4 T cells helped CD8 T cells differentiated into SLECs and together, 




Figure 2. 4 Phenotypic differences between naïve splenic WT and MHCII KO 
CD8 T cells.  
CD8 T cells in spleens of naïve WT or MHCII KO mice were analyzed by flow 
cytometry. (A) Expressions and percentages of CD44+CD62L-, CD44+CD62L+, 
CD44-CD62L+, and CD44-CD62L- cells were determined. (B)  Expressions and 
percentages of PD-1+Tim-3-, PD-1+Tim-3+, PD-1-Tim-3+, and PD-1-Tim-3- cells 
were determined. (C) Expression and percentages of CD39+Lag-3-, CD39+Lag-3+, 
CD39-Lag-3+, and CD39-Lag-3- are shown. (A-C) Bar, mean. Statistical 
significance was analyzed by two-way ANOVA. p-values: *, p<0.05; ***, p<0.001; 




Figure 2. 5 An adoptive transfer model confirms the helped vs. helpless CD8 
T cell phenotype.  
Purified polyclonal CD8 T cells from C57BL/6J mice were transferred to TCRa KO 
mice with or without Ag85-specific CD4 T cells (P25) (i.e., helped and helpless, 
respectively), and then infected with aerosolized Mtb. (A) The survival of helped, 
helpless, TCRa KO mice that received only P25 cells, and TCRa KO mice that 
didn’t receive any cells was monitored. Data were combined from 3 experiments 
using a total of 17-19 transferred mice per group and 5 TCRa KO mice that 
received no cells. The difference between the groups was statistically significant 
(p<0.0001) as determined using the log-rank test for trend. (B) Determination of 
synergy between P25 and CD8 T cells as described in the text. The theoretical 
additive benefit is calculated by the “independent effects” function, while the 
“synergy” group is the actual survival observed after transfer of P25 and CD8 T 
cells (i.e., from (A)). These two scenarios differed statistically (p<0.0001) by the 
log-rank test. (C) Lungs from TCRa KO mice that received P25 and CD8 T cells 
(helped) vs. only CD8 T cells (helpless) were analyzed at 4 and 7 wpi by flow 
cytometry to determine the frequencies of TB10.44-11 -specific CD8 T cells. (D) The 
proportion of lung KLRG1+CD127-(SLEC) and KLRG1-CD127+(MPEC) CD8 T 
cells was determined 7 wpi. Quadrant numbers represent percentages. (E) The 
frequencies of lung KLRG1+CD127- (SLEC) among total CD8 T cells was 
determined 4 and 7 wpi by flow cytometry and analyzed statistically. (C, E) Bars, 
mean ± SD. Data are representative of three independent experiments, 3-5 
mice/group. Statistical significance was analyzed by unpaired t test. p-values: **, 




Common features of “helped” and “helpless” CD8 T cell in the WT/KO and 
the adoptive transfer model 
We analyzed helped and helpless lung parenchymal CD8 T cells from the 
adoptive transfer model to determine whether they shared phenotypic 
characteristics with CD8 T cells from WT and MHCII KO mice. Importantly, we 
found that in the adoptive transfer model, helped CD8 T cells expressed more of 
the NK cell receptors 2B4 and NKG2D and transcription factor T-bet. In contrast, 
helpless CD8 T cells had higher expression of Eomes (Figure 2.6 A).  
Next, we created UMAP projections and performed PhenoGraph™ analysis 
using WT, KO, helped, and helpless CD8 T cells (Figure 2.6 B-E). In this analysis, 
we compared differences between helped vs. helpless CD8 T cells, as well as 
differences between the two models (i.e., WT/KO vs. adoptive transfer). The 
clusters were similar to those identified in the WT/KO model (Figure 2.6 C-E), with 
one additional cluster (“I”, Figure 2.6 B). Helped and helpless CD8 T cells differed 
in many clusters (Figure 2.6 C-E). Helped CD8 T cells were significantly enriched 
in cluster A and C, which contained most of the effector cells. In contrast, helpless 
CD8 T cells were more abundant in cluster F, G, and H, which contained exhausted 
cells in various states (Figure 2.6 D, E). Thus, the differences between “helped” vs. 
“helpless” CD8 T cells in the adoptive transfer model were concordant with those 
identified in the WT/KO model, indicating that the development of T cell exhaustion 
arises from a lack of T cell help and not from developmental defects in MHCII KO 
mice.  
We then compared WT to helped, and KO to helpless CD8 T cells to 
visualize differences between these two models (Figure 2.6 C, E). WT and helped 
CD8 T cells were similar except for an increased frequency of helped CD8 T cells 
in cluster E, which are progenitor exhausted CD8 T cells. Helpless CD8 T cells 
were also enriched in cluster E, indicating cluster E was characteristic of the 
adoptive transfer model. When compared to WT and helped CD8 T cells, KO and 
helpless CD8 T cells were significantly enriched in cluster F and H, which appear 
to be exhausted and terminally exhausted cells. The differences in the exhausted 
states of CD8 T cells from the WT/KO and adoptive transfer models might have 
arisen from their analysis at different time points, 8 and 6 wpi, respectively. 
Nevertheless, these data demonstrate shared features of helped and helpless CD8 
T cells from the two models. “Helped” CD8 T cells were more likely to express NK 
receptors and resemble effector CD8 T cells, while “helpless” CD8 T cells were 




Figure 2. 6 Comparison of WT/KO and adoptive transfer model finds shared 
“helped” and “helpless” characters.  
(A) Helped and helpless mice (i.e., the adoptive transfer model) were infected with 
aerosolized Mtb for 6 weeks. Anti-CD45-AF647 was injected intravenously 3 
minutes before euthanasia. Lung parenchymal (CD45iv-CD44+CD62L-) CD8 T 
cells were analyzed by flow cytometry to determine the expression of NK receptors 
(percentage) and transcription factors (MFI). The histograms show representative 
data and the accompanying graphs represent the statistical analysis. Bars, mean 
± SD. (B-E) Lung parenchymal CD8 T cells from WT/KO mice 8wpi and 
helped/helpless mice 6wpi were used to create UMAP projections and analyzed 
with PhenoGraph. (B) Nine clusters were identified with PhenoGraph analysis. (C) 
Pairwise comparisons of WT, KO, helped, and helpless lung parenchymal CD8 T 
cells were overlayed onto the UMAP projection. (D) UMAP projections were 
overlayed with expression of each indicated marker. (E) The percentage of each 
cluster among WT, KO, helped or helpless lung parenchymal CD8 T cells were 
compared statistically. Bars, mean ± SD. (A-E) Representative data of two 
independent experiments, 4-5 mice/group. Statistical significance was analyzed by 
unpaired t test (A) or two-way ANOVA (E). p values: **, p<0.01; ***, p<0.001; ****, 
p<0.0001. ns, no significant differences. 
 
  
CD4 T cell help promotes IFNγ and IL-2 production by CD8 T cells that 
recognize Mtb-infected macrophages 
To gain insight into the functional differences between “helped” vs. “helpless” 
CD8 T cells, we measured their ability to produce cytokines when stimulated. We 
showed previously that TB10.44-11-specific CD8 T cells did not efficiently recognize 
infected macrophages. As we are unaware of any class I MHC Mtb epitopes that 
are presented on Kb or Db by Mtb-infected cells, we chose to use Mtb-infected 
macrophages as a physiological stimulus. CD8 T cells from Mtb-infected WT or 
MHCII KO mice (Figure 2.7 A-C) or from Mtb-infected helped and helpless mice 
(i.e., the transfer model; Figure 2.7 D-F) were purified and cultured with uninfected 
or Mtb-infected macrophages. The CD8 T cells from WT mice produced more IFNγ, 
TNF, and IL-2 than CD8 T cells from MHCII KO mice (Figure 2.7 A-C). Similarly, 
CD8 T cells cotransferred with P25 cells produced more IFNγ and IL-2 than CD8 
T cells transferred alone (Figure 2.7 D-E). TNF production was comparable in the 
adoptive transfer model (Figure 2.7 F). Thus, we showed that CD4 T cells provide 
help for CD8 T cell production of IFNγ in both of our helped/helpless CD8 T cell 
models using Mtb-infected macrophages as a physiological stimulus. This is 
consistent with previous studies that demonstrated a reduction of IFNg-producing 
CD8 T cells in the absence of CD4 T cells [85, 87]. Additionally, we show that CD4 
T cell help is critical for CD8 T cell production of TNF and IL-2. These functional 
changes parallel the effector vs. exhausted features that distinguish “helped” vs. 

































































































Figure 2. 7 CD4 T cell help enhances CD8 T cell cytokine productions upon 
recognition of infected macrophages.  
Purified CD8 T cells from WT or MHCII KO mice 8wpi (A, B, C) or from helped or 
helpless mice (i.e., the adoptive transfer model) 7wpi (D, E, F) were cultured with 
Mtb-infected macrophages (Mf) at a CD8:Mf ratio = 1:1. IFNg (A, D), IL-2 (B, E), 
and TNF (C, F) were determined 18-24 hours later. The data are representative of 
three experiments with 5 mice/group (A-C) or two independent experiments with 
3-5 mice/group (D-F). Bars, mean ± SD. Statistical significance was analyzed by 




“Helped” CD8 T cells more effectively restrict Mtb growth than “helpless” 
CD8 T cells 
Whether helped CD8 T cells mediate better protection during Mtb infection 
is unknown. This question is difficult to address in vivo because it is difficult to 
separate the helper function of CD4 T cells from their effector function. Therefore, 
we quantified the ability of purified “helped” or “helpless” CD8 T cells to restrict 
intracellular bacterial growth in vitro. Using this approach, we found CD8 T cells 
from the lungs of WT mice inhibited Mtb growth effectively, even when the CD8: 
macrophage ratio was as low as 1:125 (Figure 2.8 A), although the potency varied 
between experiments. Bacterial control was MHCI-restricted since CD8 T cells 
were able to restrict bacterial growth in infected WT macrophages but not in 
infected KbDb KO macrophages (Figure 2.8 B). WT CD8 T cells inhibited Mtb 
growth significantly better than MHCII KO CD8 T cells (Figure 2.8 C). Interestingly, 
the colony forming unit (CFU) recovered after adding WT CD8 T cells was 
sometimes less than the input (i.e., day 1), suggesting that CD8 T cells are capable 
of promoting killing of Mtb under some conditions. These results were confirmed 
using CD8 T cells purified from Mtb-infected helped and helpless mice (i.e., the 
transfer model). Again, helped CD8 T cells inhibited bacterial growth significantly 
better than helpless CD8 T cells (Figure 2.8 D). The ability of CD8 T cells to control 
bacterial growth depended on when they were isolated from mice. As MHCII KO 
mice survive longer after Mtb infection than T cell deficient mice, CD8 T cells must 
be able to mediate some protection in vivo. We hypothesized that CD4 T cell help 
is important in maintaining the function of CD8 T cells and preventing exhaustion. 
Therefore, we compared the ability of WT and MHCII KO CD8 T cells to restrict 
Mtb growth when isolated from mice at 5 vs. 8 wpi.  MHCII KO CD8 T cells obtained 
after 5 wpi were able to inhibit intracellular bacterial growth while CD8 T cells 
isolated 8 wpi had lost their ability to restrict Mtb growth (Figure 2.8 E). WT CD8 T 
cells isolated at both timepoints similarly controlled bacterial growth. In order to 
compare experiments where Mtb grew differently, the growth from day 1 to 
endpoint was normalized and the percent inhibition by CD8 T cells was calculated. 
The 100% inhibition indicated no Mtb growth, while 0% inhibition indicated Mtb 
grew similarly as in macrophages without CD8 T cells (Figure 2.8 F).  This 
correlated with greater inhibitory receptor expression on MHCII CD8 T cells 8 wpi 
(Figure 2.8 G). These data show that “helped” CD8 T cells restricted Mtb growth 
more efficiently than “helpless” CD8 T cells, and this effect is due to a loss of 
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Figure 2. 8 “Helped” CD8 T cells are better at Mtb control than “helpless” 
CD8 T cells.  
Purified CD8 T cells from WT or MHCII KO mice at 8 wpi (A-C, and E), or purified 
CD8 T cells from helped or helpless mice (i.e, the adoptive transfer model) at 7 
wpi (D) were cultured with Mtb infected macrophages (Mf) at a CD8:Mf ratio = 1:2 
unless otherwise indicated. Macrophages were lysed 4-6 days later and the colony 
forming unit (CFU) per well was determined. (A) Purified WT CD8 T cells were 
cultured with macrophages at different T cell to macrophage ratios. (B) Purified 
WT CD8 T cells were cultured with WT or KbDb macrophages. (C) Purified WT or 
MHCII KO CD8 T cells were cultured with macrophages. (D) Purified helped or 
helpless CD8 T cells were cultured with macrophages. (E) Purified WT or MHCII 
KO CD8 T cells from 5 or 8 wpi were cultured with macrophages. (F) Percent 
inhibition by CD8 T cells from early and late timepoints was calculated. The 100% 
inhibition indicated no Mtb growth since day 1, while 0% inhibition indicated Mtb 
grew similarly to conditions that had no T cells. (G) Frequencies of PD-1+Tim-3+ 
CD8 T cells from spleens of naïve and lungs of 4 and 8 wpi mice. Bar, mean. (A-
E) The whiskers of the Box and whisker plots indicate the maximum and minimum. 
Representative of 3 (A, D), 2 (B, G),6 (C), or 4 (E) experiments. Statistical 
significance was analyzed by one-way ANOVA. p-values: **, p<0.01; ***, p<0.001; 
****, p<0.0001. ns, no significant differences.   
CD8 T cells inhibit intracellular Mtb growth through both IFNγ dependent and 
independent mechanisms 
CD8 T cells can potentially inhibit intracellular Mtb growth through producing 
IFNγ or/and cytotoxic function. To address the requirement of IFNγ signaling in 
Mtb growth inhibition, we cultured CD8 T cells with infected IFNγR KO 
macrophages. We found CD8 T cells significantly restricted Mtb growth even in 
IFNγR KO macrophages, despite there was a trend for reduced ability of CD8 T 
cells (Figure 2.9 A, B). We then tested whether perforin dependent mechanism 
was involved in Mtb growth control. CD8 T cells deficient in perforin were cultured 
with infected macrophages with different CD8 T cell to macrophage ratios. WT and 
perforin KO CD8 T cells had comparable abilities to inhibit Mtb growth (Figure 2.9 
C, D). Perforin KO CD8 T cells have been shown to have increased ability to 
produce IFNγ [98]. Thus, to exclude the possibility that more IFNγ made by perforin 
KO CD8 T cells contributed to the inhibition, we compared WT and perforin KO 
CD8 T cells’ ability to restrict Mtb growth in IFNγR KO macrophages. We showed 
perforin KO CD8 T cells didn’t have impaired ability to restrict Mtb growth even in 
IFNγR KO macrophages (Figure 2.9 D). These results suggest CD8 T cells use 
both IFNγ dependent and independent pathways to control intracellular Mtb.  
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Figure 2. 9 CD8 T cells inhibit intracellular Mtb growth through both IFNγ 
dependent and independent mechanisms.  
(A) Purified CD8 T cells at 8 wpi were cultured with infected WT or IFNγR KO 
macrophages (Mf)  at a CD8:Mf ratio = 1:2. Macrophages were lysed 6 days later 
and the colony forming unit (CFU) per well was determined. (B) Percent inhibition 
by CD8 T cells in infected WT or IFNγR KO macrophages was calculated from two 
independent experiments. The 100% inhibition indicated no Mtb growth since day 
1, while 0% inhibition indicated Mtb grew similarly to conditions that had no T cells.  
(C) CD8 T cells from WT or perforin KO mice at 8 wpi were cultured with Mtb 
infected macrophages at different CD8:Mf ratios. Macrophages were lysed 6 days 
later and the colony forming unit (CFU) per well was determined. (D) CD8 T cells 
from WT or perforin KO mice at 8 wpi were cultured with infected WT or IFNγR KO 
macrophages at CD8:Mf ratios= 1:2. Macrophages were lysed 6 days later and 
the colony forming unit (CFU) per well was determined. Statistical difference was 
analyzed by one-way ANOVA. p-values: **, p<0.01; ***, p<0.001; ****, p<0.0001. 
ns, no significant differences. 
  
Exhausted states accumulate on MHCII KO CD8 T cells as infection 
progresses 
To better characterize how the exhausted features developed on MHCII KO 
CD8 T cells, lung parenchymal CD8 T cells from MHCII KO mice were analyzed 
at 3, 5, and 8 wpi by flow cytometry. UMAP projection for each timepoint was 
created and overlayed onto each other (Figure 2.10 A). We found significant 
overlaps in UMAP projections between 3 wpi and 5 wpi, while UMAP projections 
from 5 wpi vs. 8 wpi and 3 wpi vs. 8 wpi were more separated. Phenograph 
analysis identified 11 distinct clusters and the statistical differences among 
timepoints were analyzed (Figure 2.10 C, D). Indeed, we found minimal differences 
between 3 wpi to 5 wpi. In contrast, major differences in exhausted features were 
found between 5 wpi and 8 wpi. There was a rapid accumulation of terminally 
exhausted cells (cluster j and k) between 5 wpi and 8 wpi (Figure 2.10 B, D). 
Greater frequencies of CD8 T cells from 5 wpi were found in clusters appeared to 
be exhausted progenitors (cluster e and f) (Figure 2.10 B, D). Moreover, CD8 T 
cells from 5 wpi were also enriched in cluster g. This cluster was PD1+Tbet+slamf7+, 
consisted with previous finding that exhausted cells transiently expressed effector 
signatures on the way to be terminally exhausted (Figure 2.10 B, D) [155]. We 
conclude exhausted features develop on MHCII KO CD8 T cells mostly between 
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Figure 2. 10 Exhausted states accumulate on MHCII KO CD8 T cells as 
infection progresses.  
MHCII KO mice were infected with aerosolized Mtb. Anti-CD45-AF647 was 
injected intravenously 3 minutes before euthanasia at 3, 5, and 8 wpi. Lung 
parenchymal CD8 T cells from each timepoint were used to create UMAP 
projection and analyzed with PhenoGraph. (A) Pairwise comparisons between 
timepoints were overlayed onto each other. (B) UMAP projections were overlayed 
with expression of each indicated marker. (C) 11 clusters were identified with 
PhenoGraph analysis. (D) The percentage of each cluster among timepoints were 
compared statistically. Bars, mean ± SD. Statistical significance was analyzed by 





The relative importance of CD4 and CD8 T cells for immunity to Mtb 
continues to be debated. Tackling this question is confounded by several issues. 
CD4 and CD8 T cells differ in the way they are activated. CD8 T cells survey the 
cytosol, which is sampled by MHCI, while CD4 T cells survey antigens produced 
in endosomal vesicles or acquired by endocytosis and sampled by MHCII. Thus, 
assaying T cell responses by in vitro stimulation with exogenous antigen (e.g., PPD 
or Mtb lysate) biases the results towards CD4 T cells. Optimally stimulating CD8 T 
cells requires defined epitopes or delivering the antigen into the cytosol. Thus, 
many immunogenicity studies find vaccines elicit primarily CD4 T cells responses, 
but this could be prejudiced by the stimulation conditions. Consequently, many 
investigators focus on vaccine strategies that elicit CD4 T cell effector responses. 
We hypothesize the potential of CD8 T cells to mediate protection is 
underestimated because they require CD4 T cell help to optimally express effector 
functions that inhibit Mtb growth. 
We used RNA-seq to detect differences between WT and MHCII KO CD8 
T cells during Mtb infection in the mouse model. These “helped” vs. “helpless” 
features were confirmed by flow cytometry in two independent models. Among the 
helped CD8 T cells, there were higher frequencies of SLECs and MPECs, and 
cells that expressed NK receptors. This may explain why CD4 T cells enhanced 
CD8 T cell lysis of Mtb-infected macrophages [136]. In contrast, helpless CD8 T 
cells resembled exhausted cells. We measured cytokine productions by CD8 T 
cells in response to Mtb-infected macrophages. Helped CD8 T cells secreted more 
IFNγ, TNF, and IL-2, while helpless CD8 T cells produced less cytokines. Previous 
studies found CD4 T cells enhance Mtb-specific CD8 T cell production of IFNγ [85, 
87] , and our data suggest that maintenance of cytokine production depends on 
CD4 T cells preventing CD8 T cell exhaustion. 
Since CD4 T cells mediate protection during Mtb infection, it’s difficult to 
study CD4 T cell help to CD8 T cells without the confounder of direct protection by 
CD4 T cells. Because of this, none of the previous studies addressed whether CD4 
T cell help is necessary for protection mediated by CD8 T cells. We developed a 
novel adoptive transfer model to identify characteristics of helped and helpless 
CD8 T cell responses by using P25 TCRtg CD4 T cells that provide help but only 
limited protection. The combination of polyclonal CD8 T cells plus P25 CD4 T cells 
led to a synergistic effect in the survival of Mtb-infected mice. Finally, lung CD8 T 
cells purified from both of our models and cultured with infected macrophages 
showed that helped CD8 T cells directly restricted Mtb growth more efficiently than 
helpless CD8 T cells. Without CD4 T cells in vivo, mice succumb prematurely to 
TB despite lung IFNγ levels remaining elevated [86]. Thus, it is uncertain whether 
greater CD8 T cells production of IFNγ in vivo would correlate with protection in 
the absence of CD4 T cells. These results highlight the requirement of CD4 T cells 
for protective CD8 T cell responses and indicate that compromised CD8 immunity 
likely contributes to the early death of mice lacking CD4 T cells.  
An underappreciated role of CD4 T cells is to help CD8 T cells resist 
exhaustion, a state characterized by the expression of multiple co-inhibitory 
receptors and accompanied by the gradual loss of effector functions. Exhausted 
CD8 T cells express a unique transcriptional network that inhibits their 
differentiation into effector or memory cells [153, 162]. How CD8 T cell exhaustion 
contributes to TB pathogenesis is not completely clear; nevertheless, T cells with 
features of exhaustion are detected during TB both in mice and in people [163]. 
Why helpless CD8 T cells become exhausted during the early stages of infection 
is unknown. One hypothesis is antigen persistence during chronic infection leads 
to persistent TCR engagement and exhaustion, supported by the finding that the 
transcription factors downstream of TCR signaling, including IRF4, NFAT, Nr4a1, 
Nr4a2, and Nr4a3, enhance exhaustion [164-166]. Alternatively, suboptimal 
priming of CD8 T cells in the absence of CD4 help favor the formation of exhausted 
progenitors rather than effector cells [131, 167, 168]. Our results are better 
explained by the chronic antigen stimulation model. We found a difference 
between WT and MHCII KO mice in inhibitory receptor expression and lung CFU 
by 4 wpi. We speculate that the higher bacterial burden in MHCII KO mice leads 
to CD8 T cell exhaustion.  
An area for further investigation is the molecular nature of help signals 
during TB. When CD4 T cells recognize antigen presenting cells (APC), 
CD40/CD40L interaction, combined with innate signaling by pattern recognition 
receptors, leads to DC activation, cytokine production and upregulation of co-
stimulatory molecules [134, 135]. Cytokines including IL-12, IL-15, and type I 
interferon, and co-stimulatory ligands CD70 and CD80/86, are the molecular basis 
of “help” that DCs relay to CD8 T cells [67]. In addition, CD4 T cells produce IL-2 
and IL-21, which promote CD8 T cell survival and acquisition of effector function 
[169]. Thus, CD4 T cell help CD8 T cells both directly and indirectly. IL-2 treatment 
also restored T cell responses in a mouse model, in which Mtb proteins were 
repeatedly administered to study T cell dysfunction [170]. CD8 T cells require IL-
21 to control chronic viral infection [125-127], and we showed previously that IL-
21 receptor deficiency impairs CD8 T cell responses during TB and leads to 
increased Tim-3 and PD-1 expression  [139]. Whether exhaustion of helpless CD8 
T cells develops because of reduced IL-2 or IL-21 levels needs further investigation. 
An interesting clue is that at 5 wpi, both helped and helpless CD8 T cells restricted 
Mtb growth in vitro; however, the function of helpless CD8 T cells obtained later 
during infection seemed to decline. This may indicate that “help” is needed to 
maintain effector function or prevent T cell exhaustion. 
Mtb-specific CD8 T cell responses are detected in infected people and 
animal models and are recognized as an integral part of immune response to Mtb. 
CD8 T cells were considered to play a minor role compared to CD4 T cells based 
on only moderate reduction in the survival of mice with defective CD8 T cell 
responses compared to normal mice. Here, using a variety of approaches including 
two independent in vivo models, we unequivocally show that CD4 T cells play an 
essential role in helping CD8 T cells develop into effector T cells that can restrict 
Mtb growth. These data are consistent with a greater appreciation for the role of 
CD8 T cells in primary Mtb infection and Mtb-challenge after vaccination in the 
non-human primate model [77, 78]. We suggest that vaccine strategies that 
enhance synergy between CD4 and CD8 T cells would be more effective at 
eliciting protective immunity 
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The molecular mechanisms of CD4 T cell help were addressed. We 
previously identified helped CD8 T cells as cytotoxic effector cells, and that they 
mediated protection both in vitro and in vivo. In contrast, helpless CD8 T cells were 
at different states of exhaustion. Here, we studied the involvements of IL-21, IL-2, 
and CD40-CD40L signalings in shaping the helped vs. helpless CD8 T cell 
characteristics. Whether these pathways were required for CD8 T cell mediated 
protection were also investigated. We found IL-21 promotes the cytotoxic features 
of helped CD8 T cells. In the absence of IL-21 signaling, CD8 T cells have impaired 
ability to inhibit intracellular Mtb growth. On the other hand, treating helpless mice 
with anti-CD40 agonist antibody partially restored CD8 T cell exhaustion, and we 
observed a reduction in splenic bacterial burden in anti-CD40 treated mice. Lastly, 
we showed that adding exogenous IL-2 modestly improved helpless CD8 T cells’ 
ability to restrict intracellular Mtb growth. These results suggest the complexity of 
the help signals CD4 T cells provided to CD8 T cells, in which signals directly from 
CD4 T cells and signals relayed by antigen presenting cells (APCs) are involved.     
Introduction 
 
A field remaining to be studied is the molecular mechanisms of CD4 T cell 
help in TB. CD4 T cells can directly help CD8 T cells by producing cytokines that 
support the survival, expansion, and effector functions of CD8 T cells, including IL-
21 and IL-2. In addition, CD4 T cell help can be delivered to CD8 T cells through 
antigen presenting cells (APCs). Once receiving activating signaling through CD40, 
which engages with CD40L on activated CD4 T cells, APCs upregulate expression 
of MHCI and co-stimulatory receptors and production of pro-inflammatory 
cytokines. These stimulating signals then act on CD8 T cells, shaping their 
differentiation and functions. Many studies have shown several signaling pathways 
involved in this process, however, the requirement of these pathways in promoting 
the “helped” CD8 T cell responses during TB is unknown. In this chapter, I studied 
the roles of IL-21, IL-2, and CD40-CD40L as help signals to generate optimal CD8 
T cell responses. 
IL-21, IL-2, and CD40-CD40L signaling have well-established roles in CD4 
T cell help. IL-21 is essential for CD4 T cells to sustain antiviral activity of CD8 T 
cell responses in chronic viral infection [125-127], and it maintains CD8 T cell 
function through induction of transcription factor BATF [171]. IL-2 was identified as 
an important mediator of CD4 T cell help for generating memory CD8 responses. 
IL-2 produced by CD4 T cells, or by CD8 T cells after activated by licensed DCs, 
inhibits TRAL expression and prevents apoptosis of memory CD8 T cells. CD40-
CD40L signaling was the first reported molecular mechanism of CD4 T cell help 
[134, 135]. Because of its role in activating APCs and providing stimulating signals 
to CD8 T cells, anti-CD40 agonist is included in vaccine strategies to substitute the 
need for CD4 T cells, and it has been used for cancer immunotherapy to generate 
anti-tumor responses or combined with inhibitory receptor blockade. Moreover, IL-
21 and IL-2 has been suggested to play a role in antagonizing CD8 T cell 
exhaustion. 
The contribution of these signaling pathways in protective immunity to Mtb 
has been studied. Deficiency in IL-21 signaling resulted in increased susceptibility. 
IL-21R KO mice have higher bacterial burden and succumbed early after infection, 
which has been attributed to the impaired T cell priming, expansion, and effector 
function in the absence of IL-21 signaling [139]. CD4 T cells producing IFNγ, TNFa, 
and IL-2 are associated with protection in TB, and recombinant IL-2 has been used 
as immunotherapy to pulmonary TB. CD40 KO mice also died prematurely after 
Mtb infection, although it’s likely due to defective IL-12 production. Whether these 
signals contribute to immunity against Mtb due to their role as “help signals” is 
unknown.  
We had identified “helped” vs. “helpless” CD8 T cell features previously. 
While helped CD8 T cells are effector cells with cytotoxic ability, helpless CD8 T 
cells are exhausted. We also developed a Mtb growth inhibition assay to quantify 
CD8 T cell ability to restrict Mtb in vitro. Here, we tested the requirement of help 
signals in shaping the cytotoxic vs. exhausted states on CD8 T cells. In addition, 
whether providing/ blocking help signals alters CD8 T cells’ ability to inhibit Mtb 
growth was studied. Finally, we determined whether reinvigoration of exhausted 
CD8 T cells improved Mtb control. We found IL-21 enhanced cytotoxicity of CD8 T 
cells, while anti-CD40 agonist partially restored exhausted CD8 T cell features 
after infection. Furthermore, Mtb growth inhibition by MHCII KO CD8 T cells was 
improved by IL-2, but not inhibitory receptor blockade.    
   
Results 
 
IL-21 signaling enhances NK receptor, but prevents inhibitory receptor 
expressions on CD8 T cells 
To test whether IL-21 signaling is involved in CD4 T cell help to CD8 T cells 
during TB, we measured the “helped vs. helpless” features on CD44+CD62L- CD8 
T cells in lungs of WT and IL-21R KO mice after infection. A greater percentage of 
WT CD8 T cells expressed NK receptor NKG2A/C/E, and the frequencies of 
NKG2A/C/E+NKG2D+ or 2B4+CD226+ CD8 T cells among total CD8 T cells were 
also greater in WT mice (Figure 3.1 A).  Moreover, we showed higher expression 
of transcription factor T-bet in WT CD8 T cells (Figure 3.1 B). WT and IL-21R KO 
CD8 T cells had similar frequency in co-expression of inhibitory receptors Tim-3 
and PD-1, which are usually an indicator of terminally exhausted cells. 
Nevertheless, when we performed UMAP and Phonograph analysis, greater 
frequencies of IL-21R KO CD8 T cells were found in cluster 7, which appeared to 
be terminally exhausted cells based on its expression of PD1, Tim-3, Lag3, CD39, 
and transcription factor c-Maf (Figure 3.1 C-E). These features indicate WT CD8 
T cells have effector states with cytotoxic function, while greater frequencies of IL-
21R KO CD8 T cells are exhausted. Although we identified helped vs. helpless 
features of WT and IL-21R KO CD8 T cells, the differences were much smaller 
compared to what we found in the WT/MHCII KO and the adoptive transfer model. 
This may be due to the analysis on total lung CD8 T cells rather than parenchymal 
CD8 T cells. Since intravascular CD8 T cells  didn’t interact with infected cells, they 
expressed different features and may have diluted the phenotypes we observed 
here. Nevertheless, we showed IL-21 signaling is involved in shaping helped and 
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Figure 3. 1 IL-21 signaling enhances NK receptor, but prevents inhibitory 
receptor expressions on CD8 T cells.  
WT and IL-21R KO mice were infected with aerosolized Mtb for 8 weeks. (A) 
CD44+CD62L- lung CD8 T cells were analyzed by flow cytometry to determine the 
frequencies of NK and inhibitory receptors. The mean % ± SD for each quadrant 
is indicated (n=5/group). The percentage of WT vs. KO cells in each quadrant was 
compared, and if statistically significant, is indicated in the WT quadrant. (B) The 
median fluorescence intensity (MFI) of each transcription factor, ± SD, are 
indicated. UMAP projections from the flow cytometric analysis of CD44+CD62L- 
lung CD8 T cells were overlayed between WT or KO CD8 T cells (C), or with 
expression of the indicated markers (D). (E) Eight clusters were identified using 
PhenoGraph and the percentage of each cluster among WT or IL-21R KO CD8 T 
cells were analyzed statistically. Bars, mean ± SD. Experiment was performed with 
5 mice/group. Statistical significance was analyzed by two-way ANOVA. p-values: 
**, p<0.01; ***, p<0.001; ****, p<0.0001; #, p<0.0001. ns, no significant differences. 
 
  
IL-21R KO CD8 T cells have impaired ability to control Mtb growth 
To determine whether IL-21R KO CD8 T cells lost the ability to restrict 
intracellular Mtb growth as we observed on helpless CD8 T cells from two other 
models, purified CD8 T cells from Mtb infected WT or IL-21R KO mice at 8wpi were 
cultured with Mtb infected macrophages. We showed IL-21R KO CD8 T cells had 
impaired ability to control Mtb growth at low T cell to macrophage ratio (i.e., T: 
macrophage = 1:5). We didn’t observe any difference in ability of WT and IL-21R 
KO CD8 T cells to inhibit Mtb growth at high T cell to macrophage ratio, which 
could reflect WT CD8 T cells having better cytotoxic function that required cell 
contact to mediate Mtb control. In conclusion, defective IL-21 signaling on CD8 T 
cells hindered their restriction of Mtb growth in vitro (Figure 3.2).  
  
 
Figure 3. 2 IL-21R KO CD8 T cells have impaired ability to control Mtb growth.  
Purified CD8 T cells from WT or IL-21R KO mice at 8wpi were cultured with Mtb 
infected macrophages (Mf) at different CD8 T cell to Mf ratio. Macrophages were 
lysed 6 days later and colony forming unit (CFU) per well was determined. The 
whiskers of the box plots indicate the maximum and minimum. Statistical 
significance was analyzed by one-way ANOVA (compared to d6) and multiple t 
tests (between WT and IL-21R KO CD8 T cells). P values: *, p<0.05; **, p<0.01; 
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Anti-CD40 treatment partially reverts the exhaustion feature on helpless CD8 
T cells 
We considered whether providing the “help signal” can restore the helpless 
state of MHCII KO CD8 T cells. Anti-CD40 was intraperitoneally injected into 
MHCII KO mice every week after Mtb infection, and at 7wpi, lung parenchymal 
CD8 T cells from these mice were analyzed and compared to MHCII KO mice that 
didn’t receive the treatment. We found a decreased frequency of CD8 T cells that 
expressed both PD-1 and Tim-3, but an increased frequency of CD8 T cells that 
expressed neither receptors in anti-CD40 treated MHCII KO mice (Figure 3.3 A). 
This suggested that a lower frequency of terminally exhausted CD8 T cells was 
generated following anti-CD40 treatment. Indeed, when we performed UMAP and 
PhenoGraph analysis, there was a lower frequency of anti-CD40 treated MHCII 
KO CD8 T cells in cluster k, in which appeared to be terminally exhausted cells, 
characterized by the co-expression of PD1, Tim3, Lag3, CD39, and transcription 
factor c-Maf and Eomes (Figure 3.3 C-E). Anti-CD40 treatment also decreased the 
frequency of cells in cluster g, the cluster characterized by the expression of PD-
1, Tim-3, and transcription factor T-bet and was phenotypically similar to 
exhausted cells in transition states. In contrast, anti-CD40 treatment increased the 
frequency of cells that were KLRG1+Tbet+PD1-, which were likely effector cells (i.e., 
cluster a). However, there weren’t as many effector clusters as we found in WT 
CD8 T cells. The frequencies of CD8 T cells that expressed NK receptors, 
including NKG2D, NKG2A/C/E, and 2B4, didn’t increase in anti-CD40 treated 
MHCII KO mice (Figure 3.3 A). In summary, anti-CD40 treatment partially restores 
the exhausted states of MHCII KO CD8 T cells, but doesn’t reproduce the cytotoxic 
effector cells that we observed in helped CD8 T cells.  
To see if the reverted exhaustion features correlate with control of bacterial 
burden, we compared bacterial burdens in lungs and spleens of anti-CD40 treated 
vs. non-treated MHCII KO mice. Although the bacterial burdens in lungs were 
comparable, we found a reduced splenic bacterial burden in anti-CD40 treated 
compared to the non-treated MHCII KO mice. The similar bacterial burdens in 
lungs perhaps reflect the modest restoration of exhaustion, and the absence of 
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Figure 3. 3 Anti-CD40 treatment reverts the exhaustion feature on helpless 
CD8 T cells.  
Anti-CD40 was intraperitoneally injected into aerosolized Mtb infected MHCII KO 
mice at day 8 post infection, and once every week until 7 wpi. (A) Anti-CD45-AF647 
was injected intravenously 3 minutes before euthanasia of anti-CD40 treated or 
untreated mice, and lung parenchyma (CD45iv-CD44+CD62L-) CD8 T cells were 
analyzed by flow cytometry to determine the frequencies of NK and inhibitory 
receptors. The mean % ±	SD for each quadrant is indicated. The percentage of 
cells between anti-CD40 treated and untreated in each quadrant was compared, 
and indicated in the untreated quadrant if statistically significant. (B) The median 
fluorescence intensity (MFI) or the average percentage of cells expressing each 
transcription factor, ± SD, are indicated. UMAP projections from the flow cytometric 
analysis of lung parenchymal CD8 T cells were overlayed between anti-CD40 
treated or untreated group (C), or with expression of the indicated markers (D). (E) 
Nine clusters that were identified using PhenoGraph, and clusters that were 
phenotypically similar to clusters found in Figure 2.10 were assigned with the same 
letters. The percentage of each cluster among anti-CD40 treated or untreated KO 
CD8 T cells were analyzed statistically. Bars, mean ± SD. Experiment was 
performed with 5 mice/group. Statistical significance was analyzed by two-way 





Figure 3. 4 Anti-CD40 treatment reduces bacterial burden in spleens of MHCII 
KO mice.  
Anti-CD40 was intraperitoneally injected into aerosolized Mtb infected MHCII KO 
mice at day 8 post infection, and once every week until endpoint. At 7 wpi, anti-
CD40 treated or untreated mice were euthanized and bacterial burden at lungs 
and spleens were determined. Experiment was performed with 5 mice/group. Bars, 
mean ±	SD. Statistical significance was analyzed by unpaired t test. **, p<0.01. ns, 














































IL-2 slightly enhances the inhibition of Mtb growth by CD8 T cells 
IL-2 is a known “help signal” that CD4 T cells deliver to improve CD8 T cell 
survival and function. Moreover, IL-2 treatment has been used to revert T cell 
exhaustion. We tested whether adding exogenous IL-2 when co-culturing CD8 T 
cells and macrophages improved CD8 T cells’ ability to inhibit Mtb growth. We 
found that adding IL-2 slightly enhanced the inhibition by both WT and MHCII KO 
CD8 T cells, although this effect was neither statistically significant nor dose-
dependent (Figure 3.5 A-C). The modest improvement by WT CD8 T cells was 
likely due to the great inhibition they already mediated in the absence of IL-2. 
Despite the limited improvement of IL-2 treated compared to non-treated MHCII 
KO CD8 T cells, IL-2 treated MHCII KO CD8 T cells marginally inhibited Mtb growth 
compared to the condition without CD8 T cells (i.e., d6) (Figure 3.5 A,B). 
Furthermore, anti-IL-2 blocking antibody had minimal effect on control of Mtb 
growth by WT CD8 T cells, nor did it aggravate the loss of function on MHCII KO 
CD8 T cells (Figure 3.5 A). In summary, adding IL-2 in vitro has limited effects to 
restore the ability of MHCII CD8 T cells. 
 
Figure 3. 5 IL-2 treatment marginally enhances CD8 T cells’ ability to inhibit 
Mtb growth.  
(A-B) Purified CD8 T cells from WT or MHCII KO mice at 8 wpi were cultured with 
Mtb infected macrophages (Mf) at a ratio CD8: Mf =1:3 in the presence of 100U/ml 
IL-2, unless indicated, or 25 ug/ml of anti-IL-2. Macrophages were lysed 6 days 
later and colony forming unit (CFU) per well was determined. (C) Percent inhibition 
by CD8 T cells with or without 100U/ml of IL-2 from (A) and (B) was calculated. 
The 100% inhibition indicated no Mtb growth since day 1, while 0% inhibition 
indicate Mtb grew similarly to conditions that have no CD8 T cells. The whiskers 
of the box plots indicate the maximum and minimum. Statistical significance was 
analyzed by one-way ANOVA (A-B) and Mixed-effects analysis (C). p values: *, 
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Inhibitory receptors blockade does not improve MHCII KO CD8 T cells to 
control Mtb growth 
Inhibitory receptor blockade has been used to revert T cell exhaustion. We 
tested whether in the presence of anti-inhibitory receptor blocking antibodies, 
MHCII KO CD8 T cells controlled intracellular Mtb growth. CD8 T cells from Mtb 
infected WT or MHCII KO mice at 8wpi were purified and cultured with infected 
macrophages in the presence of anti-PD1, anti-Tim-3, combination of anti-PD1 and 
anti-Tim-3, or isotype antibodies. Macrophages were lysed after 6 days and plated 
to assay intracellular Mtb burden. MHCII KO CD8 T cells marginally controlled Mtb 
growth when given anti-Tim3, but failed to inhibit Mtb growth in the presence of 
anti-PD1 or both anti-PD1 and anti-Tim-3 antibodies (Figure 3.6). Inhibitory 
receptor blockade didn’t enhance the control by WT CD8 T cells as expected, since 
low frequencies of WT CD8 T cells expressed these inhibitory receptors. We 
conclude inhibitory receptor blockade doesn’t restore the ability of MHCII KO CD8 
T cells to restrict Mtb growth.   
 
Figure 3. 6  Inhibitory receptors blockade does not restore MHCII KO CD8 T 
cells to control intracellular Mtb growth.  
Purified CD8 T cells from WT or MHCII KO mice at 8wpi were cultured with Mtb 
infected macrophages at a ratio CD8 T: M =1:3 in the presence of 25 ug/ml of anti-
PD-1, anti-Tim-3, combination of anti-PD-1 and anti-Tim-3, or isotype control. 10 
µm of TB10.44-11 and 32A309-318 peptides were added to enhance CD8 T cell 
recognition in one of the conditions. Macrophages were lysed 6 days later and 
colony forming unit (CFU) per well was determined. The whiskers of the box plots 
indicate the maximum and minimum. Statistical significance was analyzed by one-










































































WT CD8 + Mφ Mφ only KO CD8 + Mφ 
Discussion 
 
In this chapter, the molecular mechanisms of CD4 T cell help during TB 
were addressed. The signaling pathways involved in promoting cytotoxic function 
and preventing exhaustion of  CD8 T cells, and their requirements of Mtb restriction 
in vitro or in vivo need to be investigated.  IL-21, IL-2, and CD40-CD40L signaling 
were tested because of their well-established roles in CD4 T cell help, and their 
suggested contribution in immunity to Mtb. I found IL-21 and IL-2 signaling played 
roles in the inhibition of intracellular Mtb growth. The ability of CD8 T cells to control 
Mtb growth in vitro were decreased in the absence of IL-21 signaling, while adding 
exogenous IL-2 modestly improved Mtb growth restriction. In contrast, anti-CD40 
treatment partially reverted exhausted CD8 T cells from lungs of Mtb-infected 
MHCII KO mice. Although anti-CD40 treatment had limited effect on diminishing 
Mtb burden in lungs of MHCII KO mice, we observed a significant reduction in 
splenic bacterial burden.  
Our results highlighted the role of IL-21 signaling in cytotoxic CD8 T cells. 
CD8 T cells from infected IL-21R KO mice express a lower percentage of NK 
receptor NKG2A/C/E and 2B4, suggesting they had impaired cytolytic functions. 
Indeed, IL-21R KO CD8 T cells have decreased ability to inhibit Mtb growth when 
cultured with infected macrophages. These findings are consistent with a previous 
study that IL-21 was indispensable for generating cytotoxic CD8 T cells during 
chronic LCMV infections [129]. The effector functions CD8 T cells used to inhibit 
intracellular Mtb growth is not fully uncovered.  Although we showed perforin KO 
CD8 T cells’ ability to control Mtb growth wasn’t impaired, we didn’t address Fas-
FasL or TNF dependent cytotoxicity. Moreover, the deficiency of perforin may be 
compensated by other redundant pathways (i.e. Fas-FasL and/or TNF pathway). 
Thus, we suggested cytolysis pathways were involved in CD8 T cell mediated 
inhibition of intracellular Mtb growh.  
Interestingly, I found that CD8 T cells from infected IL-21R KO mice showed 
minimal T cell exhaustion, which may seem to contrast with previous findings that 
T cells from IL-21R KO mice were more exhausted [139], but in this study, Booty 
and Barreira-Silva et al measured exhausted features at a later timepoint (i.e., 
16wpi). However, IL-21R KO mice have higher bacterial burden in lungs and 
spleens even at early timepoints. Since high bacterial loads may lead to T cell 
exhaustion, the role of IL-21 in T cell exhaustion needs to be carefully 
characterized. Indeed, infected mice with BCG expressing IL-21 didn’t diminish the 
formation of exhausted cells [172]. The involvement of IL-21 independent of 
antigen stimulation to inhibit T cell exhaustion needs to be addressed.   
Whether introduction of “help signals” can substitute the need for CD4 T 
cells and promote effective CD8 T cell responses is of great interest. Anti-CD40 
agonistic antibody has been used in cancer therapy because of its function to 
activate T cell responses against tumor associated antigens, and to directly target 
tumor cells that expressed CD40. Treating Mtb infected mice with anti-CD40 
antibody partially improved the exhausted states on lung CD8 T cells from MHCII 
KO mice, but this improvement didn’t reduce Mtb burden in lungs.  Nevertheless, 
we observed a significant decrease in splenic bacterial burden on anti-CD40 
treated MHCII KO mice. CD8 T cells have been previously shown to provide better 
protection in spleens compared to lungs, but it remains unknown whether the 
reduction in splenic Mtb burden was mediated by CD8 T cells or through APCs in 
spleen that were activated by CD40-anti-CD40 antibody interaction. In addition, 
exogenous IL-2 was added to enhance the performance of helpless CD8 T cells in 
vitro. I showed IL-2 treatment modestly enhanced control of Mtb growth by MHCII 
KO CD8 T cells. Whether IL-2 treated MHCII KO CD8 T cells controlled Mtb growth 
because the reinvigoration of exhausted features or/and the improvement of 
effector functions was not addressed. The role of IL-2 in CD8 T cell mediated 
control of Mtb growth was further complicated by the fact that blocking IL-2 
signaling had negligible effect. This result seemed to suggest IL-2 wasn’t produced 
in the culture, however, we detected a significant amount of IL-2 produced by 
helped CD8 T cells when cultured with infected cells.   
Finally, whether reinvigoration of exhausted CD8 T cells by inhibitory 
receptor blockade led to enhanced Mtb growth control in vitro was tested. We 
showed anti-PD1, anti-Tim-3, and the combination of these two antibodies have 
minimal effect on improving the functions of exhausted CD8 T cells. A previous 
study showed TCF1+CXCR5+ exhausted progenitor cells respond to inhibitory 
receptor blockade, and these precursor cells proliferated and differentiated into 
cells that have effector functions. Although purified total CD8 T cells were used in 
the CFU assay, a cluster of PD1intTCF1+Eomes- progenitor cells were previously 
identified in MHCII KO CD8 T cells. How this cluster of cells responded to inhibitory 
receptor blockade needs further characterization. In addition, whether 
administration of anti-inhibitory receptor blocking antibodies in vivo results in a 
more significant change is another direction for future studies.  
In summary, the signals CD4 T cells provide to help CD8 T cells are 
complicated. We showed mediators directly from T cells (i.e., IL-21 and IL-2) and 
through APCs (i.e., CD40-CD40L) are involved. However, deficiency in any of 
these signaling pathways has limited effect on CD8 T cell responses compared to 
the absence of CD4 T cells, suggesting CD4 T cells help CD8 T cells by multiple 
mechanisms. Moreover, our results suggest the possibility that individual signaling 
pathways may play a different role in shaping CD8 T cell responses. For example, 
IL-21 promotes cytotoxicity of CD8 T cells, while signaling through CD40 prevents 
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Mtb becomes “dormant” in response to low oxygen and the high immune 
pressure inside granulomas. 18b, a streptomycin auxotroph of Mtb, provides a 
model to study immune responses during Mtb dormancy. We leveraged the 18b 
property of manageable growth, and used it to study CD8 T cell responses in WT 
and MHCII KO mice with the same bacterial burden. In contrast to Erdman 
infection, we found lower 18b specific responses in MHCII KO mice after infection, 
suggesting CD4 T cell help is indispensable to generate CD8 T cell responses in 
18b infection. Moreover, I observed an altered hierarchy of immunodominance, in 
which dominant TB10 specific CD8 T cells decreased, while subdominant 32A 
specific CD8 T cells increased.   
To study protection mediate by CD8 T cells, purified CD8 T cells from 18b 
infected WT or MHCII KO mice were transferred into TCRα KO mice before 
challenge with Mtb. Unexpectedly, we found MHCII KO CD8 T cells mediated 
better protection in TCRα KO mice. Through a series of experiments, we showed 
the deficiency in MHCII molecule perhaps during development, but not deficiency 
in CD4 T cells, contributed to MHCII KO CD8 T cell mediated protection.  This 
supports previous findings that MHCII molecules play role in regulating CD8 T cell 
behavior. I suggest this model provides insights into the mechanisms of CD8 T cell 
mediated protection.    
Introduction 
 
It is estimated that a quarter of the world population has latent TB, an 
asymptomatic phase of infection that can persist lifelong.  At this stage, immune 
responses against Mtb are triggered and contain the infection through “walling off” 
the bacteria with granulomas. This results in a low oxygen and nutrient, but high 
immune pressure environment for Mtb. In response to the harsh environment, Mtb 
turns itself into a non-replicating and low metabolic “dormancy” state. To better 
understand this dormancy state, several animal models has been proposed, and 
18b, a streptomycin auxotroph of Mtb, becomes a useful model among these 
strategies [21, 173, 174]. 18b grows in the presence of streptomycin, enters a non-
replicating phase in a streptomycin free environment, and resumes growth when 
streptomycin is reinstated. Despite trying to be invisible to the immune system, 18b 
has shown to elicit T cell responses.   
Because the growth of 18b is easily manipulated, we explored the possibility 
to use 18b to answer the remaining question we have for CD4 T cell help: Does 
the lack of CD4 T cell help or the increased bacterial burden in the absence of CD4 
T cells contribute to CD8 T cell exhaustion? Despite our finding using two 
independent models that CD4 T cell help limits CD8 T cell exhaustion and that 
anti-CD40 agonist antibody partially reverts exhaustion, the question is not 
completely answered. We thought to address this question in a condition that 
helped and helpless CD8 T cells under same antigen stimulation, which can be 
achieved through infecting WT and MHCII KO mice with 18b and maintaining 
similar bacterial burden in these mice with control of streptomycin. However, we 
found lower CD8 T cells responses in MHCII KO mice after 18b infection, making 
it not an ideal model to study exhaustion. Moreover, when we transferred purified 
CD8 T cells from 18b infected WT or MHCII KO mice into TCRα KO mice, we 
unexpectedly found MHCII KO CD8 T cells mediated better protection against the 
subsequent infection. 
Through a series of experiments, we showed that deficiency in MHCII 
molecules, not CD4 T cells, contributed to MHCII KO CD8 T cell mediated 
protection.  Although it’s unexpected, the link between MHCII molecules and CD8 
T cells has previously been shown. Several lines of evidence suggest MHCII 
molecules can regulate CD8 T cell proliferation and functions. Triggered by the 
recognition of self peptide-MHC complex, T cells undergo homeostatic proliferation 
in lymphopenic conditions.  While CD4 T cells fail to proliferate in MHCII deficient 
lymphopenic conditions, CD8 T cells have substantial proliferation in MHCI 
deficient lymphopenic environment. This proliferation is abolished in both MHCI 
and MHCII deficient conditions, suggesting a role for MHCII in regulating CD8 T 
cells homeostatic proliferation [158]. Moreover, this regulation has been shown to 
occur through Lag3, a ligand of MHCII molecules. CD8 T cells from MHCII KO 
mice express more Lag3, and Lag3 blockade by antibody further enhances CD8 T 
cell expansion [158]. Lag3 deficient CD8 T cells are reportedly having greater 
ability to infiltrate into tumor [175], which are associated with tumor control. In this 
chapter, I characterized CD8 T cell responses after 18b infection in WT and MHCII 
KO mice, and reported a role of MHCII molecules in regulating CD8 T cell functions, 







Comparable 18b burdens in WT and MHCII KO mice 
We sought to dissociate the role of CD4 T help in preventing CD8 T cell 
exhaustion from the role that CD4 T cells play in maintaining low bacterial burden, 
leading to less antigen stimulation of CD8 T cells. To study CD8 T cell responses 
from WT and MHCII KO mice with same bacterial burden, we intravenously (iv) 
infected mice with 18b, a streptomycin auxotroph of Mtb. Streptomycin was given 
intraperitoneally (ip) to support 18b growth for the first week after infection. 
Consistent with previous studies, 18b grew in the presence of streptomycin, and 
persisted in mice for a long time without streptomycin (Figure 4.1 A). Importantly, 
the bacterial burdens were similar in lungs and spleens between WT and MHC II 
KO mice (Figure 4.1 B). 
  
 
Figure 4. 1 Bacterial burdens after 18b infection.  
WT (A) or WT and MHCII KO (B) mice were intravenously infected with 18b. 
Streptomycin was intraperitoneally given to infected mice every day for a week. 
Bacterial burdens in lung (A) or lung and spleen (B) were determined at indicated 
timepoints (A) or 4 weeks post infection (wpi) (B). Bar, median (A) and mean±SD 
(B). Statistical significance was analyzed by one-way ANOVA (A) or unpaired t test 
























































Greater 18b specific CD8 T cell responses are generated in the presence of 
CD4 T cells  
To measure 18b specific CD8 T cell responses, we assayed TB10.4 and 
32A specific CD8 T cells from lungs and spleens of WT or MHCII KO mice at 4 wpi. 
We detected higher frequencies of both TB10.4 and 32A specific CD8 T cells in 
lung of WT mice (Figure 4.2 B,C).  Despite smaller differences, perhaps reflecting 
the variation in individual mice, we observed more TB10.4 and 32A specific CD8 
T cells in lung of WT mice (Figure 4.2 D,E). Interestingly, we found an altered 
hierarchy in immunodominant CD8 T cell responses in 18b infection compared to 
Erdman infection. The frequency of dominant TB10.4 specific CD8 T cells, which 
could account for 30-40% of total CD8 T cells in the lungs after Erdman infection, 
deceased in 18b infection. This was comparable to the frequency of subdominant 
32A specific CD8 T cells (Figure 4.2 B,C,I,J) .  
We previously found TB10.4 specific CD8 T cells didn’t recognize infected 
macrophages [102]. To measure the portion of CD8 T cells elicited by 18b infection 
that recognized infected macrophages, we used Mtb-infected macrophage 
ELISPOT (MIME) assay that was developed in our lab [107]. In this assay, purified 
CD8 T cells were cultured with H37Rv-infected macrophages, and the recognition 
of infected macrophages was measured by IFNγ production. The proportion of 
CD8 T cells recognizing infected macrophages was calculated by the number of 
spots developed in the ELISPOT assay versus the number of CD8 T cells added. 
Consistent with a previous report, the frequencies of CD8 T cells recognizing 
infected macrophages were low, but there were greater frequencies of CD8 T cells 
in WT mice that recognized infected macrophages (Figure 4.3 A).  
The frequencies of TB10.4 and 32A specific CD8 T cell responses were 
even lower in spleens of 18b infected mice. Nevertheless, there was a greater 
frequency, and a modest increase in the number, of 32A specific CD8 T cells in 
WT mice (Figure 4.2 I,K). The frequency and number of TB10.4 specific CD8 T 
cells were similar in WT and MHCII KO mice in most of experiments, but a 
significantly greater frequency and number were observed in WT mice when all 
the data were combined and analyzed (Figure 4.2 J,L)  Furthermore, we detected 
very few spots with MIME assay when purified splenic CD8 T cells were cultured 
with infected macrophages, indicating a very low proportion of CD8 T cells from 
spleens of 18b infected mice recognized infected cells (Figure 4.3 B).  
We analyzed the differentiation of CD8 T cells by determining the 
frequencies of short-lived effector cells (SLEC) and memory precursor cells 
(MPEC). The frequencies of SLEC were modestly increased in lung CD8 T cells 
from WT mice (Figure 4.2 F). In contrast, there was much greater frequency of 
MPEC in MHCII KO mice, although we can’t rule out the presence of naïve CD8 T 
cells base on this flow cytometry gating (Figure 4.2 G). The frequencies of SLEC 
and MPEC were similar in spleen CD8 T cells from WT and MHCII KO mice (Figure 
4.2 M,N). Collectively, greater 18b specific CD8 T cell responses were generated 
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Figure 4. 2 Greater 18b specific responses are generated in WT mice after 
infection.  
WT and MHCII KO mice were iv infected with 18b, and given streptomycin for first 
week after infection. At 4 wpi, CD8 T cells from lung (A-G) or spleen (H-N) were 
analyzed by flow cytometry to determine the number of CD8 T cells (A, H) and the 
frequencies (B,C,I, J) and absolute number (D,E,K, L) of TB10.4 and 32A specific 
CD8 T cells. The frequencies of KLRG1+CD127-(SLEC) or KLRG1-CD127+(MPEC) 
among CD8 T cells were determined (F, G, M, N). Colors were used to distinguish 
individual experiment. Bar, grand mean. Statistical difference was analyzed by 
unpaired t test for pooled data. p-values: *, p<0.05; **, p<0.01; ***, p<0.001; ****, 





Figure 4. 3 The frequencies of CD8 T cells from 18b infected WT and MHCII 
KO mice that recognized infected macrophages.  
WT and MHCII KO mice were iv infected with 18b, and given streptomycin for first 
week after infection. At 4wpi, CD8 T cells from lung or spleen were purified and 
cultured with H37Rv infected or uninfected TG-PMs. The frequencies of CD8 T 
cells secreted IFNγ were determined by IFNγ ELISPOT. Bar, mean±SD.  
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18b immunized MHCII KO CD8 T cells mediate better protection in 
immunodeficient mice  
To study the ability of CD8 T cells to mediate protection in vivo, purified CD8 
T cells from 18b infected mice can be transferred into TCRα KO mice before 
challenging the recipients with Mtb. Since less than a million of CD8 T cells per 
mouse can be purified from lungs of 18b infected mice, we transferred splenic CD8 
T cells from 18b infected WT or MHCII KO mice into TCRα KO mice, and the 
recipients of WT or MHCII KO CD8 T cells and mice received no cells were then 
challenged with aerosolized Mtb. We found neither WT nor MHCII KO CD8 T cells 
mediated protection in lungs of recipients compared to mice that didn’t receive any 
CD8 T cells, while MHCII KO CD8 T cells unexpectedly reduced bacterial burden 
in spleens of recipients (Figure 4.4).   
  
 
Figure 4. 4 CD8 T cells from 18b infected MHCII KO mice confer protection in 
spleens of TCRα KO mice.  
CD8 T cells were purified from spleen of 18b infected WT or MHCII KO mice at 4 
wpi, and adoptive transferred into TCRα KO mice. TCRα KO mice received WT or 
MHCII KO CD8 T cells, and TCRα KO mice didn’t received CD8 T cells were then 
infected with aerosolized Mtb. Mtb burden in lungs and spleens of recipient mice 
were determined at 3 wpi. Data were combined from three independent 
experiments. Bar, median. Statistical difference was analyzed by one-way ANOVA. 
p-values: *, p<0.05; **, p<0.01; ***, p<0.001; ****, p<0.0001. ns, no significant 






































Very few TB10.4 and 32A specific CD8 T cells in the recipient mice 
To address potential mechanisms contributing to the protection mediated 
by MHCII KO CD8 T cells, we characterized CD8 T cell responses after challenge 
in lungs and spleens of recipients of WT or MHCII KO CD8 T cells. We found 
MHCII KO CD8 T cells tend to proliferate more in the recipients compared to WT 
CD8 T cells, although this didn’t occur in all the experiments (Figure 4.5 A,B). 
Furthermore, not all the recipients generated CD8 T cells specific to TB10.4 or 32A, 
and even in the mice that generated TB10.4 or 32A specific CD8 T cells, the 
frequencies of these cells were very low (Figure 4.5 C-F). This may be contributed 
by the limited number of TB10.4 and 32A specific precursor cells that were 
transferred into TCRα KO mice. Nevertheless, it was less likely that TB10.4 and 
32A specific CD8 T cells contributed to the protection since the low frequencies of 














































































Figure 4. 5 Very few TB10.4 and 32A specific CD8 T cells are detected in 
recipient mice.  
Splenic CD8 T cells were purified from 18b infected WT or MHCII KO mice at 4 
wpi, and adoptively transferred into TCRα KO mice. TCRα  KO mice received WT 
or MHCII KO CD8 T cells were then infected with aerosolized Mtb, and CD8 T cells 
from lung (A,C,D) and spleens (B,E,F) of TCRα  KO recipient mice were analyzed 
by flow cytometry at 3 wpi to determine the number of CD8 T cells (A,B) and 
frequencies of TB10.4 and 32A specific CD8 T cells (C-F). Colors are used to 
distinguish individual experiment. Bar, mean±SD (A,B) and grand mean (C-F). 
Statistical difference was analyzed for individual experiment with unpaired t test, 
and the results are labeled next to the legends.  p-values: *, p<0.05; **, p<0.01; ***, 
p<0.001; ****, p<0.0001. ns, no significant differences.      
Virtual memory (VM) cells less likely contribute to MHCII KO CD8 T cell 
mediated protection 
Virtual memory cells (VMs) are antigen inexperienced, memory-like CD8 T 
cells that can be found in naïve mice. These cells are thought to arise from 
homeostatic proliferation, although never having experienced foreign antigens, 
they quickly respond and expand during infection [176-178]. More importantly, they 
can produce IFNγ and mediate bystander killing driven by cytokines [176]. We 
tested whether VMs mediated the protection we observed from recipients of MHCII 
KO CD8 T cells. VMs are CD44hiCD49dlo and can be distinguished from naïve and 
true memory cells by the expression of these two markers (Figure 4.6 A). However, 
we didn’t observe more VMs in naive MHCII KO mice, and these VMs didn’t 
expand after Mtb infection or transferred into TCRα KO mice (Figure 4.6 B-D). 































































































Figure 4. 6 MHCII KO mice have less virtual memory (VM) cells.  
Lung naïve (CD44loCD49dlo), VM (CD44+CD49d-), and memory (CD44+CD49d+) 
CD8 T cells were characterized using flow cytometry to determine cell numbers. 
(A) Representative flow plots showing gating strategy. Number of naïve, VM, and 
memory CD8 T cells in naïve WT and MHCII KO mice (B), Mtb infected WT and 
MHCII KO mice at 4wpi (C), and in TCRα KO mice received purified total WT or 
MHCII KO CD8 T cells at 3 weeks post transfer (D). Bars, Bar, mean±SD. 
Statistical differences was analyzed by one-way ANOVA. p-values: *, p<0.05; **, 
p<0.01; ***, p<0.001; ****, p<0.0001. ns, no significant differences. 
 
  
CD8 T cells from 18b immunized, CD4 T cell depleted mice do not confer 
protection in immunodeficient mice 
We considered whether the ability of MHCII KO CD8 T cells to protect the 
recipients arose from the absence of CD4 T cells, or it arose from the 
developmental or intrinsic differences in MHCII KO CD8 T cells. Although it’s hard 
to associate CD4 T cell “help” to an impaired ability of CD8 T cells, one possible 
hypothesis could be that CD4 T cells promote the differentiation of SLEC cells, 
which could be less proliferative and thus mediate poor protection in recipients. To 
test the requirement of CD4 T cells, purified WT CD8 T cells from CD4 T cell 
depleted mice were used. Anti-CD4 was used to deplete CD4 T cells from 
C57BL/6J mice before infecting with 18b, and was continuously injected every five 
days for first three weeks after infection. Purified splenic CD8 T cells from CD4 T 
cell depleted or intact mice were transferred into TCRα KO mice before these 
recipients were challenged with Mtb. We didn’t observe protection in lungs or 
spleens of recipients by CD8 T cells, regardless they were from intact or CD4 T 
cell depleted mice. This result shows an intrinsic feature of MHCII KO CD8 T cells 
contributed to the protection (Figure 4.7).   
We also tested whether less TB10.4 and 32A specific CD8 T cells found in 
MHCII KO CD8 T cells after 18b infection resulted from the absence of CD4 T cells. 
The frequencies and numbers of TB10.4 and 32A specific CD8 T cells from lungs 
and spleens of 18b infected intact or CD4 T cell depleted mice were determined 
by flow cytometry. Although it’s not statistically significant, we observed a trend for 
decreased frequencies and numbers of TB10.4 and 32A specific CD8 T cells in 
lungs in the absent of CD4 T cells (Figure 4.8 A-D). We barely detected any TB10.4 
specific CD8 T cells in spleens of neither mice, but we found more 32A specific 
CD8 T cells in spleen of intact mice. These results suggested CD4 T cells, at least 
in part, contributed to generate 18b specific CD8 T cell responses.    
  
 
Figure 4. 7 Purified CD8 T cells from 18b infected, CD4 T cell depleted mice 
don’t protect TCRα KO mice.  
CD4 T cells were depleted from C57BL/6J mice by anti-CD4 antibody before 18b 
infection, and anti-CD4 was consciously given every five days for the first three 
weeks of infection. Purified CD8 T cells from CD4 T cell depleted or intact mice 
were transferred into TCRα mice, and the recipients were challenged with 
aerosolized Mtb. Bacterial burden in lungs and spleens of recipients were 
determined at 3 weeks post challenge. Bars, median. Statistical difference was 


















































Figure 4. 8 TB10.4 and 32A specific CD8 T cells in intact or CD4 T cell 
depleted mice after 18b infection.  
Anti-CD4 antibody was used to deplete CD4 T cells from C57BL/6J mice before, 
and consciously given for the first three weeks after 18b infection. The frequencies 
(A,B,E) and number (C,D,F) of TB10.4 or 32A specific CD8 T cells from lungs (A-
D) and spleens (E,F) of intact or CD4 T cell depleted mice were determined by 
flow cytometry. Bars, median. Statistical difference was analyzed by unpaired t test. 
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MHC II KO CD8 T cells express more Lag3 and are higher proliferative in 
immunodeficient mice 
Previous study suggested that MHCII KO CD8 T cells were hyperreactive 
under lymphopenic conditions, which was due to the lack of inhibition signals 
delivered through Lag3-MHCII interaction. This study showed greater expression 
of Lag3 on MHCII KO CD8 T cells, and administration of anti-Lag3 blockade further 
enhanced the expansion [158]. To validate the hyperproliferative feature of MHCII 
KO CD8 T cells, we transferred proliferation-dye-stained WT and MHCII KO CD8 
T cells at a 1:1 ratio into TCRα KO mice and assayed their proliferation based on 
the dilution of dye after 4 days. We found MHCII KO CD8 T cells proliferated more 
compared to WT CD8 T cells (Figure 4.9 A). We then measured Lag3 expression 
on CD8 T cells using flow cytometry, and confirmed MHCII KO CD8 T cells had 
greater expression of Lag3 in basal level (i.e., naïve cells), after Mtb infection, and 

























































































































Figure 4. 9 MHCII KO CD8 T cells express more Lag-3 and are 
hyperproliferative in TCRα KO mice.   
(A) 106 of naïve WT (CD45.1) and MHCII KO CD8 T cells (CD45.2) were labeled 
with proliferation dye e450 and transferred into TCRα KO mice. TCRα KO were 
euthanized at 4 days post transfer, and CD8 T cells from lymph nodes and spleens 
were analyzed by flow cytometry. The mean % ±SD for each quadrant is indicated 
(n=3/group). (B-D) The frequencies of CD8 T cells expressed CD44+Lag3+ were 
analyzed by flow cytometry from spleens of naïve WT and MHCII KO mice (B), 
lungs and spleens of Mtb infected WT and MHCII KO mice at 4wpi (C), and lungs 
and spleens of TCRα  KO mice received purified WT or MHCII KO CD8 T cells at 
3 weeks post transfer (D). Bars, median. Statistical difference was analyzed by 
unpaired t test. p-values: *, p<0.05; **, p<0.01; ***, p<0.001; ****, p<0.0001. ns, no 
significant differences.   
  
Anti-Lag3 blockade does not enhance the protection by MHCII KO CD8 T 
cells in immunodeficient mice 
We considered whether the hyperreactive nature of MHCII KO CD8 T cells 
correlated to the protection they mediated in the recipients. To answer this 
question, anti-Lag3 blockade was given to recipients of MHCII KO CD8 T cells, 
and we tested whether MHCII KO CD8 T cells would expand and bacterial burden 
in recipients can be further reduced. Purified splenic, 18b immunized MHCII KO 
CD8 T cells were transferred into TCRα KO mice before the recipients were 
challenged with aerosolized Mtb. Anti-Lag3 blockade was given to the recipients 
on the day of cell transfer, and every three days for three weeks. The recipients 
were euthanized, and the bacterial burden and CD8 T cell number in lungs and 
spleens were determined. There was comparably low bacterial burden in spleens 
between anti-Lag3 treated and control group (Figure 4.10 A), which may due to 
the low starting dose (i.e, day 1) of this aerosol infection and led to an inconclusive 
result. Nevertheless, the number of CD8 T cells in recipients didn’t increase in 
response to anti-Lag3 blockade. Thus, we concluded anti-Lag3 blockade had 
minimal effect in promoting the proliferation or protection of MHCII KO CD8 T cells 
(Figure 4.10 B).  
 
Figure 4. 10 Anti-Lag3 blockade does not enhance the protection by MHCII 
KO CD8 T cells in immunodeficient mice.  
Purified CD8 T cells from 18b infected MHCII KO mice were transferred into TCRα 
KO mice before the recipients were challenge with aerosolized Mtb. Anti-Lag3 
blocking antibody was given to the recipients every three days until euthanasia at 
3 wpi. Bacterial burdens (A) and the number of CD8 T cells (B) in lungs and 
spleens of recipients were determined. Bars, median. Statistical difference was 
analyzed by unpaired t test. p-values: *, p<0.05; **, p<0.01; ***, p<0.001; ****, 



















































































Mtb infected MHCII KO CD8 T cells do not confer protection in 
immunodeficient mice  
We hypothesized that 18b immunization was necessary for the protection 
in recipients medicated by MHCII KO CD8 T cells. To test whether CD8 T cells 
from Mtb infected MHCII KO mice transfer protection, purified CD8 T cells from 
spleens of aerosolized Mtb infected WT or MHCII KO mice were transferred into 
TCRα KO mice, and these recipients were then challenged with aerosolized Mtb. 
The recipients of MHCII KO CD8 T cells outlived the mice that received WT CD8 
T cells in first experiment, but this result was not repeatable (Figure 4.11A). 
Conflicting results of bacterial burdens were also observed. Although MHCII KO 
CD8 T cells showed modest protection in lungs of recipients in first experiment, 
neither WT nor MHCII KO CD8 T cells mediated protection in second experiment 
(Figure 4.11 B). In summary, we concluded that CD8 T cells from Mtb infected 
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Figure 4. 11 Mtb infected MHCII KO CD8 T cells don’t confer protection in 
immunodeficient mice.  
Purified CD8 T cells from aerosolized Mtb infected WT or MHCII KO CD8 T cells 
were transferred into TCRα KO mice. (A) The survival of recipients after challenged 
with aerosolized Mtb. Two independent experiments are shown. The statistical 
difference between the recipients of WT or MHCII KO CD8 T cells was determined 
by the log-rank test. (B) Bacterial burden in lungs and spleens of recipients and 
TCRα KO mice receiving no cells were determined at 3 wpi. Two independent 
experiments are shown. Statistical difference was determined by one-way ANOVA. 
p-values: *, p<0.05; **, p<0.01; ***, p<0.001; ****, p<0.0001. ns, no significant 
differences.   
Discussion 
 
In this chapter, we reported an unexpected protective role of 18b immunized 
MHCII KO CD8 T cells against Mtb, which was likely because of its development 
in the absence of MHCII molecules and becoming hyperproliferative. Interestingly, 
fewer immunodominant antigens, including TB10.4 and 32A, specific CD8 T cells 
were found in MHCII KO mice. This contrasted to our previous finding that in 
Erdman infections, CD4 T cells were dispensable to generate Mtb specific CD8 T 
cell responses. CD4 T cells can help CD8 T cells through activating APCs, a 
process called “licensing”. The licensed APCs upregulate MHCI and co-stimulatory 
receptors and produce pro-inflammatory cytokines. However, APCs can also be 
activated by innate signaling through TLRs. Thus, infections that induced strong 
type I IFN response on APCs, for example, LCMV infection, may bypass the need 
for CD4 T cell help and directly activate CD8 T cells. It’s likely that in a more virulent 
Erdman infection, the need for CD4 T cell help was bypassed, whereas it’s 
indispensable to generate antigen specific CD8 T cell responses in 18b infection. 
This reduced TB10.4 and 32A specific responses were also observed in CD4 
depleted mice after 18b infection.    
We also observed an altered hierarchy of immunodominance in CD8 T cell 
responses. There was a decrease in frequencies of CD8 T cells specific for 
immunodominant epitopes TB10.4, while an increase in CD8 T cells specific for 
subdominant epitopes 32A. Why TB10.4 response is immunodominant among Mtb 
specific CD8 T cells is unknown. Nevertheless, immunodominance is a 
phenomenon that often described in viral infection, and it’s in part contributed by 
the number, type, and ability of APCs to present certain epitopes over others [179-
183]. Moreover, dominant CD8 responses can actively suppressed subdominant 
responses [180-182]. The mechanisms for swapping positions in the hierarchy is 
also unclear, although it’s be shown peripheral routes of infection (i.e., id and sc) 
sharpen the immunodominance, while systemic infection (i.e., iv and ip) generate 
broader repertoire [184]. We previously showed TB10.4 could be a decoy antigen 
that Mtb actively uses to evade CD8 T cells [102, 106]. Therefore, whether iv 
infection with 18b elicits broader immune responses (i.e., less immunodominant) 
that can confer better protection needs further investigation.   
To address the mechanisms of protection mediated by 18b immunized 
MHCII KO CD8 T cells, we first addressed whether 18b elicited more CD8 T cells 
recognizing infected macrophages in MHCII KO mice. Since immunodominant 
antigens are likely decoy antigens, we hypothesize CD8 T cells that recognize non-
dominant antigens presented on infected cells are protective [102, 106]. We 
performed MIME assay [107], in which the frequencies of CD8 T cells that secreted 
IFNγ when cultured with infected macrophages were assayed. We didn’t find a 
greater frequency of MHCII KO CD8 T cells recognized infected cells. We 
considered whether the absence of CD4 T cells or the deficiency of MHCII 
contributed to MHCII KO CD8 T cell mediated protection. We depleted CD4 T cells 
in 18b infected mice and transferred purified CD8 T cells into TCRα KO mice, but 
WT CD8 T cells from CD4 T-depleted mice didn’t protect TCRα KO mice upon Mtb 
challenge. Thus, an intrinsic or development defect, which resulted from lack of 
MHCII, contributed to the protection by MHCII KO CD8 T cells. We then tested the 
possibility that MHCII KO mice have more VM cells, which can lead to protection. 
In contrast, we found naive MHCII KO mice have less VM cells, and this population 
didn’t expand after Mtb infection.  Finally, we studied the Lag3-MHCII regulation 
on CD8 T cells. We suspected the hyperproliferative nature in the absence of 
MHCII made CD8 T cells more protective. We determined whether the expansion 
of MHCII KO CD8 T cells when engaging anti-Lag3 antibody can reduced bacterial 
burden. We injected anti-Lag3 blocking antibody into TCRα KO mice that received 
MHCII KO CD8 T cells, but found no further reduction in bacterial burdens after 
treatment. However, the bacterial burdens in both anti-Lag3 treated and untreated 
mice were really low.  
A spectrum of T cells with different proliferation capacities can be detected 
after Mtb infection and vaccination [46, 185-188]. The less differentiated cells, 
characterized by the expression of PD-1 and/or CXCR3, are thought to have better 
proliferation and cell renewal ability compared to the terminally differentiated 
CX3CR1, KLRG1, and/or Tim3 expressing cells [46, 185]. The less differentiated 
states are associated with better protection in TB partially because of their greater 
ability to produce IL-2 and/or multiple cytokines (i.e., polyfunctionality) [186]. In 
contrast, terminally differentiated cells expressing predominately IFNγ are 
associated with poor protection [186, 189, 190]. After vaccination, eliciting T cells 
with less differentiated, proliferative central memory phenotypes are associated 
with vaccine induced protection [188, 191]. Interestingly, we found lower 
frequencies of SLEC in MHCII KO mice after 18b infection, but detected greater 
frequencies of SLEC in mice receiving MHCII KO CD8 T cells compared to mice 
that received WT CD8 T cells. This suggested MHCII KO CD8 T cells were able to 
differentiate into terminally effector cells after being transferred into TCRα KO mice. 
A better characterization of MHCII KO CD8 T cells in the recipients are needed to 
fully uncover the mechanisms of protection. 
CD8 T cells mediate modest protection after Mtb infection even in 
immunodeficient mice. Here, we provided evidence that CD8 T cells can confer a 
two-log-reduction protection in spleens of recipients. Although we didn’t find 
protection in lungs after infection, this preferential control in spleens by CD8 T cells 
have been shown previously. We attributed this protection to at least partially the 
intrinsic nature of MHCII KO CD8 T cells. The lack of Lag3- MHCII interaction alters 
the activation/proliferation threshold of MHCII KO CD8 T cells, leading to greater 
proliferation and differentiation in lymphopenic recipients. However, a prior 18b 
infection, which generated a distinct immune response than virulent Mtb, may also 
contribute to the protection. Moreover, the iv route of immunization was recently 
demonstrated to induce strong local and systemic immune responses after 
vaccination, leading to robust protection against Mtb in NHP [76]. Thus, a better 
characterization of immune responses induced by iv infection of 18b is needed. I 
suggest that this model provides a unique opportunity to study CD8 T cell mediated 
protection against Mtb.        
  
CHAPTER V: DISCUSSION 
 
“Unity is strength.” This proverb states the foundation of human society, and 
it’s also the strategy our immune system uses when facing intruding pathogens. 
CD4 T cells are called T helper cells because of their role in regulating other 
immune cells. Many studies have shown an effective CD8 T cell response during 
viral infection and cancer depends on CD4 T cells. These signals that CD4 T cells 
provide to CD8 T cells are referred to CD4 T cell help. In Mtb infection, the relative 
importance of CD8 T cells in protective immunity has been debated. This 
contention arose from the observation that CD8 T cells play minimal role in 
experimental mouse model. We argue that in these studies, the contribution of 
CD8 T cells was evaluated as an individual cell type, which could be 
underestimated in the absence of CD4 T cell help. In this dissertation, I 
characterize “helped” vs. “helpless” CD8 T cell responses during Mtb infection and 
address how CD4 T cells provide help to CD8 T cells. I show CD4 T cell help has 
a significant impact on primary CD8 T cell responses, and CD8 T cells depend on 
CD4 T cells to mediate protection during TB.  In the following sections, I discuss 
the impact of CD4 T cell help in CD8 T cell effector function and exhaustion, 
separately. Lastly, I reassess CD8 T cells’ role in protective immunity to Mtb in the 
light of our findings and newly emerging results.   
 
 
CD4 T cell help enhances CD8 T cell effector function 
In chapter II, we used multiple unbiased approaches to study the role of 
CD4 T cell help in shaping CD8 T cell responses. We performed RNA-seq analysis 
on total lung CD8 T cells from Mtb infected WT and MHCII KO mice, validated the 
transcriptional signatures on lung parenchymal CD8 T cells using flow cytometry, 
and conducted cluster analysis on single cell data acquired by flow cytometry. We 
found “helped” CD8 T cells were clusters of effector cells with cytotoxic features, 
and contained a cluster that appeared to be memory precursors. In contrast, 
“helpless” CD8 T cells were in different states of exhaustion. The helped vs. 
helpless CD8 T cell features were confirmed with an adoptive transfer model in 
which CD8 T cells were transferred with or without Ag85b specific CD4 T cells into 
TCRα KO mice. Similar phenotypic differences between CD8 T cells that received 
help or not were found in this model. Thus, we identified shared characteristics on 
helped vs. helpless CD8 T cells from two independent models.   
The effector features on helped CD8 T cells correlated with their greater 
functions. Helped CD8 T cells produced more IFNγ, TNF, and IL-2 when cultured 
with infected macrophages. The impaired ability of CD8 T cells to produce IFNγ 
during TB in the absence of CD4 T cell has been shown by two groups using 
different approaches [85, 87]. Bold et al. performed direct intracellular staining 
without re-stimulation to assess IFNγ production in vivo. They found the 
frequencies of IFN+ CD8 T cells correlated with the frequencies of IFN+ CD4 T cells 
[85]. In an adoptive transfer model in which CD4 T cells were depleted or non-
depleted from splenocytes before transferred into RAG KO mice, Green et al. 
showed the number of Mtb specific CD8 T cells and IFNγ production by CD8 T 
cells decreased without CD4 T cells [87]. We extended these findings showing 
CD4 T cells regulated IFNγ production by CD8 T cells with an overall impact on 
the transcriptome. Indeed, pathways associated with IFNγ production and 
regulation were enriched on WT CD8 T cells. The requirement of CD4 T cells for 
TNF and IL-2 production by CD8 T cells hasn’t previously been reported. TNF 
synergizes with IFNγ to activate infected macrophages, promoting their 
microbicidal activity. IL-2 promotes CD8 T cell survival and expansion. These 
findings emphasized the essential role CD4 T cell played in regulating CD8 T cell 
effector functions.  
An unexpected finding was that CD4 T cells enhanced NK receptor 
expression on CD8 T cells. Cytotoxic CD8 T cells with various surface receptors 
typically expressed by NK cells were described in leprosy and TB [75]. Balin and 
colleagues found that NK receptor expression on CD8 T cells was associated with 
their ability to produce cytotoxic granule proteins. CD8 T cells that expressed the 
greatest variety of NK receptors were the ones that secreted all perforin, granzyme, 
and granulysin [75]. A previous study addressed the requirement of CD4 T cells 
for CD8 T cell cytotoxicity by comparing the ability to of CD8 T cells from WT or 
CD4 KO mice to lyse target cells [136], but the result was complicated by later 
findings that CD4 KO mice contained MHCII restricted CD4 T cells. Nevertheless, 
we found helped CD8 T cells from two independent models expressed more NK 
receptors, suggesting greater cytolysis ability of helped CD8 T cells.   
How CD4 T cells provided help shaping CD8 T cell responses during TB 
was addressed in Chapter III. We focused on IL-21, IL-2, and CD40-CD40L 
signaling pathways because these pathways have well-established roles as “help 
signals”, and their requirements in protective immunity in TB were implied. With 
“helped” and “helpless” features we defined previously, we determined whether 
manipulating pathways mentioned above alters CD8 T cell characteristics. I found 
IL-21 was essential for cytotoxic features of CD8 T cells, and CD8 T cells deficient 
in IL-21 signaling had diminished ability to restrict intracellular Mtb growth. In 
contrast, anti-CD40 agonist antibody didn’t promote cytotoxic signatures on CD8 
T cells, although it partially reverted CD8 T cell exhaustion. These results indicated 
signals directly from T cells (i.e., IL-21) and signals relayed by DCs (i.e., CD40-
CD40L) were both involved in shaping CD8 T cell responses. However, one help 
signal failed to reproduce the full impact of CD4 T cells, suggesting CD4 T cells 
helped CD8 T cells using multiple pathways.   
 An unanswered question is when and how long CD4 T cell help is needed. 
The requirement of IL-21 to sustain CD8 T cell response in chronic viral infection 
suggests the need for a persistent CD4 T cell help [125-127]. We found helpless 
CD8 T cells purified from mice at 5 wpi inhibited Mtb growth, but they lost ability to 
restrict Mtb as infection progressed, consistent with the rapid accumulation of 
terminally exhausted cells between 5 to 8 wpi. However, we can’t rule out 
suboptimal priming in the absence of CD4 T cell help makes CD8 T cells prone to 
lose functions. It’s known that CD4 T cell help during priming, but not after, is 
important for generating functional memory responses [109, 110], which is 
regulated through imprinting epigenetic states on CD8 T cells [112, 192].  Thus, 
the signals CD8 T cells received during priming has a long-term effect on their 
differentiation. The fact that progenitor exhaustion cells form under conditions 
when DCs express less MHCI and co-stimulatory molecules reinforces this idea 
[131]. To address this question, CD4 T cell depletion can be performed after CD8 
T cells are primed, and whether CD8 T cells express helped features without 
persistent signals from CD4 T cells should be assessed.  
 
CD4 T cell help prevents CD8 T cell exhaustion  
A previous underappreciated role of CD4 T cell help is to prevent CD8 T 
cell exhaustion. Through a sequence of analyses including RNA-seq, flow 
cytometry, and clustering using UMAP and Phenograph, we identified 4 clusters 
of cells in different exhausted states from MHCII KO CD8 T cells. Furthermore, the 
exhausted features on MHCII KO CD8 T cells associated with their loss control of 
Mtb in vitro. T cell exhaustion describes a state in which T cells gradually lose 
proliferation ability and effector functions and upregulate inhibitory receptors on 
cell surface. Exhausted T cells are frequently reported in chronic viral infections 
and tumors. In TB, T cell exhaustion is also observed, although its contribution to 
pathogenesis remains inconclusive. T cells from peripheral blood of active TB 
patients have greater inhibitory receptor PD-1 expression compared to healthy 
donors, and anti-PD1 blockade enhances their proliferation and effector functions 
[193-195]. The T cell dysfunction and apoptosis correlated with Mtb loads [186, 
190]. In experimental mice, the expression of PD-1 and Tim-3 on T cells marks the 
exhausted state, correlating with impaired functions [163]. In NHP models, despite 
the expression of inhibitory receptor PD-1, LAG-3, and CTLA-4 is detected on T 
cells in lung tissue [196, 197], it appears that T cells in granulomas are not 
exhausted [198]. Tolerogenic rather than exhausted T cells are found in 
granulomas. Nevertheless, our results validated the exhausted features on CD8 T 
cells in lungs of infected mice.    
How helpless CD8 T cells become exhausted is still unanswered. There are 
several hypotheses explaining the formation of exhausted T cells. The most 
accepted hypothesis is the antigen persistence in chronic infection leads to 
constant TCR engagement. The term “exhaustion” nicely describes this hypothesis. 
It is supported by studies showing transcription factors in the proximal downstream 
of TCR signaling, including IRF4, NFAT, and Nr4a, enhance exhaustion [164-166]. 
Another hypothesis is the suboptimal priming leads to T cell exhaustion [167]. This 
hypothesis arose from the observation that exhausted cells can be detected from 
early stage of chronic infection. It’s also explained by recent studies showing that 
terminally exhausted cells derived from a population of TCF1+ “progenitor” cells. 
The fact that not all the cells, but a specific progenitor population develops 
exhaustion, suggesting a population that isn’t properly primed eventually becomes 
exhausted. Priming with DCs that have decreased MHCI and co-stimulatory 
molecule expression enhances the formation of  TCF1+ progenitor cells also 
supports this hypothesis [131]. Finally, the lack of appropriate cytokines, for 
example IL-2 and IL-21, is associated with T cell exhaustion.  
The above hypotheses are not mutually exclusive, and all the 
circumstances could happen in the absence of CD4 T cells, leading to CD8 T cell 
exhaustion. In many infections, including TB, bacterial burdens increase in the 
absence of CD4 T cells. In addition, CD8 T cells are activated with “licensed” DCs 
that received help signals from CD4 T cells. Thus, CD8 T cells are less likely being 
properly primed in the absence of CD4 T cells. We found that the terminally 
differentiated effector cells decrease, while TCF1+ exhausted progenitor cells form 
without CD4 T cells, suggesting the “helpless priming” favors the formation of 
exhausted progenitor cells. Lastly, CD4 T cells are the main producers of IL-2 and 
IL-21. In our study, Mtb burdens in lungs and spleens were higher in MHCII KO 
mice even as early as 4 wpi, and this correlated with MHCII KO CD8 T cells 
expressed more PD-1 and Tim-3 at this stage. The frequencies of MHCII KO CD8 
T cells expressing both PD-1 and Tim-3 increased as the infection progressed. 
This may indicate that antigen persistence was the cause of CD8 T cell exhaustion. 
However, it is possible that suboptimal priming or diminished IL-2 and/or IL-21 
production in MHCII KO mice also contributed to this.  
To further differentiate whether the increased bacterial burden or the lack 
of help signals in the absence of CD4 T cells leads to CD8 T cell exhaustion, 
helped and helpless T cells needs to be compared in an environment where they 
receive similar antigen stimulation. We thought to leverage Mtb strain 18b, a 
streptomycin auxotroph, to address this question. Since 18b depends on 
streptomycin to grow, we gave streptomycin to 18b infected WT and MHCII KO 
mice, and found similar bacterial burdens between these mice after streptomycin 
withdrawal. However,18b infection elicited weaker Mtb specific CD8 T cell 
responses in MHCII KO mice, which complicated the comparison of exhaustion 
between WT and MHCII KO CD8 T cells. A future plan is to generate T cell chimeric 
mice with Ag85b specific CD4 T cells, WT CD8 T cells, and IL-21R KO CD8 T cells. 
In this model, exhausted features developed on helped and helpless CD8 T cells 
can be addressed independent of antigen stimulation. 
In conclusion, CD4 T cells have an indispensable role to prevent CD8 T cell 
exhaustion through several mechanisms. These results suggest exhaustion may 
cause CD8 T cells to lose effector functions, and introducing mediators that revert 
exhaustion may improve their function. Although we found IL-2 or inhibitory 
receptor blockade had minimal role to restore CD8 T cells’ ability to restrict 
intracellular Mtb growth in vitro, these mediators could potentially improve CD8 T 
cell functions in vivo.  
 
Helped CD8 T cells are protective 
Whether “helped” CD8 T cells mediate protection needs to be addressed. 
The relative importance of CD4 and CD8 T cells during TB is contested and conflict 
observations on human and experimental NHP and mice have been reported. Mice 
deficient in CD4 T cells are extremely susceptible to Mtb infection, while mice 
deficient in CD8 T cells survive relatively long. This seems to be supported by the 
“experiment of nature” wherein AIDS patients have higher risk to develop active 
TB diseases. Although there is no equivalent evidence to prove the requirement 
for CD8 T cells, a lack of human mutations or diseases that compromised CD8 T 
cell responses may never have occurred in a TB-prevalent area.   
We argue lack of CD4 T cell help contributes to the ineffectiveness of CD8 
T cells. In experimental mouse models, CD8 T cells’ role is evaluated in 
experiments using antibody depletion, adoptive transfer, and genetic KO. However, 
these studies frequently assess CD8 T cells’ contribution in conditions where their 
function could be compromised (i.e., helpless). Whether helped CD8 T cells are 
more protective is a challenging question to answer, because the direct protection 
from CD4 T cells could be a cofounder whenever the “help” is introduced. 
Therefore, this question hasn’t been adequately addressed in previous studies. In 
Chapter II, we used two different approaches to address this question. Using an 
adoptive transfer model in which polyclonal CD8 T cells were transferred with or 
without Ag85b specific CD4 T cells into TCRα KO mice, we proved CD4 and CD8 
T cells synergistically enhanced survival of recipient mice. This synergy was 
established by calculating a survival curve in a scenario where CD4 and CD8 T 
cells work independently, and we showed mice received both CD4 and CD8 T cells 
actually survived longer than the hypothesized scenario. In addition, purified 
helped or helpless CD8 T cells were cultured with infected macrophages to 
quantify their abilities to inhibit Mtb growth. Helped, but not helpless, CD8 T cells 
restricted Mtb growth. Collectively, these results showed helped CD8 T cells 
mediate better protection. Therefore, the susceptibility of mice deficient in CD4 T 
cells is likely exacerbated by compromised CD8 T cell responses. 
Whether CD4 T cells promote effective CD8 T cells in NHP model is 
unknown. Few studies employed CD4 T cell depletion in NHP and even fewer 
evaluated CD8 T cell responses. Nevertheless, Lin and colleagues showed 
reduced CXCR3+ CD8 T cells in CD4 T cell depleted cynomolgus macaques [199]. 
Although the functions of CXCR3+ CD8 T cells were not fully elucidated, the 
expression of CXCR3 was associated with polyfunctionality of CD8 T cells. 
Interestingly, they found not all the CD4 depleted macaques reactivated from an 
established latent infection. This was consistent with another study reported by 
Foreman and colleagues, in which they showed a group of latently infected rhesus 
macaques didn’t develop reactivation after SIV infection, despite CD4 T cell 
numbers severely decreased in all the macaques [200]. While Lin et al. attributed 
these resistant macaques to incomplete deletion of CD4 T cells, Foreman’s group 
found CD8 T cells from these macaques had increased granzyme B production. 
Whether CD4 T cell help is essential in NHP needs further investigation.   
Nevertheless, CD8 T cells seem to play a more notable role in NHP 
compared to mice. This may due to the fact that NHP, like humans, express 
granulysin and group 1 CD1, whereas mice don’t have orthologs of these genes. 
Granulysin is a protein that has microbicidal ability, while group 1 CD1 can present 
Mtb lipid antigens to CD1 restricted CD8 T cells. Both molecules directly associate 
with CD8 T cell function, thus supporting the idea that NHP (and human) CD8 T 
cells are more effective. The role of CD8 T cells in NHP was best demonstrated in 
the study by Chan and colleagues, in which they depleted CD8 T cells from BCG 
immunized rhesus macaques using antibody, and found BCG induced protection 
was totally abolished in sequential challenge [78]. It’s unclear whether CD8 T cells 
played role in BCG induced protection, or they conferred protection in challenge 
without BCG, but this experiment demonstrated an indispensable role of CD8 T 
cells.  
Several vaccine candidates that conferred significant protection were also 
reported to induce significant CD8 T cell responses. Darrah and colleagues 
showed intravenous administer of BCG (iv BCG) remarkably protected rhesus 
macaques, with 6 out of 9 macaques had no sign of infection [76].  Kaushal and 
colleagues reported aerosolized mutant Mtb∆sigH protected rhesus macaques 
[79]. In both studies, CD8 T cell responses were detected in BAL and blood after 
vaccination. Although the underlying mechanisms whereby these vaccines elicit 
CD8 T cell responses, and whether strong CD8 T cell responses contribute to 
vaccine induced protection needs further investigation, these results imply the 
importance of CD8 T cells. Interestingly, the safety of iv BCG and aerosolized 
Mtb∆sigH to use in AIDS patients has been addressed. Despite being proved to 
be safe, the efficacies of these vaccines in AIDS patients have not been reported. 
Whether CD8 T cells contribute to vaccine induced protection in AIDS patients is 
an important question to address.  
In the light of emerging results, I suggest CD8 T cell responses should be 
considered and assessed in designing TB vaccines. Both our findings in mice and 
recent studies in NHP emphasize the role of CD8 T cells, which was previously 
underestimated. Despite some vaccines eliciting CD8 T cell responses as 
discussed above, current vaccine strategies focus on generating a durable CD4 T 
cell response. We suggest vaccines eliciting both CD4 and CD8 T cell responses 
are more likely to be successful than vaccines only generating CD4 T cell 
responses. The focus on CD4 T cell responses and their ability to produce 
cytokines may in part reflect the difficulty to elicit CD8 T cell responses through 
vaccination. While CD4 T cells recognize antigens that entered endocytic 
pathways and presented on MHCII molecules, CD8 T cells recognize peptides 
presented on MHCI, which are sampled from cytoplasm. Therefore, most of 
vaccine strategies including attenuated live bacteria, inactivated bacteria, and 
subunit protein elicit predominantly CD4 T cell responses. Nevertheless, the use 
of replication-deficient viral vectors encoding Mtb antigens provide a tool to 
generate CD8 T cell responses. Indeed, Hansen and colleagues reported a 
successful viral vector vaccine that was tested in NHP [77]. In this study, rhesus 
macaques were vaccinated with rhesus CMV vectors encoding 9 different Mtb 
antigens, and this vaccine conferred protection when used as booster vaccine with 
BCG or used as prime and booster vaccine without BCG.  Strong Mtb specific 
memory CD8 T responses were detected in vaccinated macaques. Although the 
correlation of CD8 T cells and protection wasn’t established this study, it 
demonstrated that a vaccine strategy eliciting CD8 T cell responses can confer 
protection.  
To sum up, newly emerging data suggest the need to reassess the role of 
CD8 T cells in Mtb infection. We found helped CD8 T cells mediated protection in 
infected mice, and recent findings in NHP also highlighted the essential role of CD8 
T cells. We infer that vaccines eliciting both CD4 and CD8 T cell responses are 
more likely to be successful, and that strategies generating both CD4 and CD8 T 
cell responses should be carefully considered in future development.   
 
CD8 T cell function 
Despite emerging data suggesting that CD8 play an indispensable role 
during TB, the molecular mechanisms of CD8 T cell mediated protection are not 
fully elucidated. In this section, I discuss the potential pathways CD8 T cells may 
use to confer protection. CD8 T cells can secrete protective cytokines including 
IFNγ, TNF, and IL-2, and they have cytotoxic ability. To determine the effector 
functions used by CD8 T cells to inhibit intracellular Mtb growth, CD8 T cells 
deficient in perforin and/or macrophages deficient in IFNγR were co-cultured and 
Mtb growth in macrophages was determined. Despite having lower efficacy, CD8 
T cells can significantly inhibit Mtb growth in IFNγR KO macrophages. This 
indicates CD8 T cells control Mtb replication through IFNγ dependent and 
independent mechanisms. In contrast, perforin KO CD8 T cells were fully able to 
control intracellular Mtb growth. A previous study reported increased IFNγ 
production in perforin KO CD8 T cells [98]. Thus, to exclude the possibility that 
enhanced IFNγ by perforin KO CD8 T cells contributes to the inhibition, the ability 
of WT vs. perforin KO CD8 T cells to control Mtb growth in IFNγR KO macrophages 
was tested. Both WT and perforin KO CD8 T cells inhibited Mtb growth with 
comparable ability. CD8 T cells can use several pathways for cytolysis, including 
exocytosis of cytotoxic granule proteins (i.e., perforin dependent), production of 
TNFa, and Fas-FasL engagement. Cell lines derived from infected animals or 
human have been used to study the cytotoxic mechanisms CD8 T cell used to kill 
target cells. While some cell lines exclusively use either perforin or Fas-FasL 
dependent pathway, others use multiple mechanisms [53, 98, 99]. It’s likely these 
cytolytic mechanisms are redundant. Thus, deficiency in perforin may be 
compensated by other cytotoxicity pathways. 
Another unanswered question is whether CD8 T cells have any unique role 
in protective immunity against Mtb. Although CD8 T cells can secrete many of the 
same cytokines as CD4 T cells, CD4 T cells are the main producers in most cases. 
Nevertheless, studies showed that CD8 T cells may be particularly crucial in some 
circumstances. In the 1980s, Orme and Collins showed that CD8 T cells from 
infected donor mice protected immunodeficient recipients from challenge. In this 
study, CD8 T cells conferred better protection in high dose aerosol infection, while 
CD4 T cells were more important in low dose aerosol infection [57]. These data 
are supported by Chen and colleagues through experiments in NHP showing CD8 
T cell depletion abolished BCG medicated protection in high dose challenge [78]. 
These results may be explained by the fact that CD8 T cells preferably recognize 
heavily infected cells [108]. Patankar and colleagues also found CD8 T cells 
produced more IFNγ when cultured with infected cells that have high MOI, while 
CD4 T cells responded to infected cells with low MOI and plateaued when cultured 
with heavily infected cells [107]. Collectively, these data suggest CD8 T cells play 
a role in immune surveillance and have greater control in heavily infected cells.  
Whether CD8 T cells confer protection at particular time and location during 
Mtb infection is also postulated. The hypothesis that CD8 T cells are more 
important during the chronic phase of infection comes from observations that mice 
deficient in cytolytic pathways (i.e., perforin or Fas-FasL) lose control of bacterial 
burden only at later times [65, 101]. Similarly, van Pinxteren and colleagues found 
CD8 T cells were uniquely needed during latent infection [201]. In this study, anti-
mycobacterial drugs were used after infection to establish a low bacterial burden, 
latent phase. CD8 T cell depletion, but not CD4 T cell depletion, during this phase 
increased bacterial burden significantly [201]. CD8 T cells may also be specialized 
to control systemic infection. Although there is no direct evidence for this theory, 
we observed 18b immunized MHCII KO CD8 T cells reduced bacterial burden in 
spleens, but not in lungs, of recipient mice after infection. A related result was 
reported previously by Feng and colleagues [60]. They found CD8 T cells from 
BCG immunized mice protected spleens of RAG KO mice from following infection, 
but have limited control of bacteria burden in lungs [60]. Moreover, in experiments 
using anti-CD40 agonist antibody to provide a “help signal” to infected MHCII KO 
mice, we only observed reduced bacterial burden in spleens compared to 
untreated mice. These data suggest CD8 T cells exert better control in spleens 
than lungs. This differential protection between lung and spleen was previously 
reported by Sakai and colleagues who found that IFNγ had greater control of 
splenic bacterial burdens than burdens in lungs [37]. However, IFNγ mediated 
mechanisms are unlikely to explain the preferential protection exerted by CD8 T 
cells in spleen because CD4 T cells secrete more IFNγ. Other possible hypotheses 
include that CD8 T cells are more easily recruited to spleen, or they are better at 
recognizing infected cells in spleen. 
A unique function of CD8 T cells described in many infections and cancer 
is their cytotoxic ability. Although CD8 T cells’ cytotoxic function in TB has been 
studied in vitro, to prove the requirement of these cytolysis pathways in vivo has 
shown to be challenging. Perforin, Fas, and FasL KO mice only succumb a little 
early than WT mice after infection [65, 101]. Therefore, to conclude the contribution 
of CD8 T cell cytotoxic ability in protective immunity is difficult, and the fact that NK 
and some CD4 T cells also express these cytotoxic molecules further complicates 
the explanation. However, the modest phenotypes in mice deficient in cytotoxicity 
pathways may also result from the lack of human granulysin gene ortholog. 
Granulysin is a cytotoxic granule protein that can directly lyse extracellular Mtb or 
kill intracellular Mtb through perforin dependent mechanism. Using scRNA-seq, 
Gideon and Hughes et al. uncovered a previously unappreciated role of cytotoxic 
CD8 T cells in NHP. By comparing cellular compositions in restrictive vs. 
permissive granulomas, Gideon and Hughes identified cellular features that 
associated with Mtb control. Among these protective cells, a cluster of conventional 
T cells that expressed transcripts of multiple cytotoxic granule proteins and NK 
receptors showed the strongest correlation with protection. These cytotoxic CD8 T 
cells are also reported in human leprosy [75]. Interestingly, CD8 T cells expressing 
the widest variety of NK receptors secrete granulysin, granzymes, and perforin, 
while CD8 T cells with fewer NK receptors only express one or two of the cytotoxic 
granule proteins.  
The importance of individual effector pathway in CD8 T cell mediated 
protection is not fully understood. The difficulty remains in the redundancy of 
effector functions within cytotoxicity pathways and between cytokine and cytolysis 
mediated pathways. Therefore, unbiased approaches including scRNA-seq may 
be particularly useful in studying these effector functions. Unraveling the 
requirement of effector pathways is needed to fully uncover the role of CD8 T cells 
role in immunity to Mtb.  
 
Conclusion 
A better delineation of protective immune responses against Mtb is the 
foundation to design better vaccines. This would facilitate identifying vaccine 
elicited responses that correlate with protection, and inform the evaluation of 
potential candidates. To achieve this aim, we need to understand how different 
elements of our immune system interact. In this dissertation, I uncovered the 
significant role of CD4 T cell help in shaping CD8 T cell responses during TB.  I 
identified “helped” vs. “helpless” CD8 T cell features, and showed helped CD8 T 
cells mediated better protection. These results and recent findings in NHP model 
collectively suggest CD8 T cell responses should be considered for vaccine design. 
We predict that vaccines which elicit both CD4 and CD8 T cell responses are more 
likely to be successful. Moreover, “help signals” can be included in the vaccine 
strategy to generate optimal CD8 T cell responses. The potential candidates for 
this purpose include anti-CD40 agonist, recombinant IL-2, and IL-21. This could 
be particularly important for designing effective TB vaccines for AIDS patients that 
have compromised CD4 T cells.   
  
CHAPTER VI: MATERIALS AND METHODS 
Experimental Model and Subject Details 
Mice 
IL-21R KO, P25 TCRtg, MHCII KO, and TCRa KO mice were purchased from 
Jackson Lab and bred locally. C57BL/6J, perforin KO, IFNγR KO mice were 
purchased from Jackson Lab. KbDb KO mice were a generous gift from Dr. Kenneth 
Rock (University of Massachusetts Medical School) [202]. Experimental mice were 
7-12 weeks old and sex-matched. In adoptive transfer experiments, 7-12 weeks 
old, sex-matched TCRa KO mice from different litters were randomly assigned for 
receiving P25, CD8, or both cells. All animal studies were conducted using the 
relevant guidelines and regulations, and approved by the Institutional Animal Care 
and Use Committee at the University of Massachusetts Medical School (UMMS) 
(Animal Welfare A3306-01), using the recommendations from the Guide for the 
Care and Use of Laboratory Animals of the National Institutes of Health and the 
Office of Laboratory Animal Welfare.  
 
Mtb strain 
The Erdman strain of Mycobacterium tuberculosis, which has been passaged 
through mice, was used for aerosol infection as described [203]. 18b was used for 
intravenous infection. H37Rv or CDC1551 strain was used for in vitro infection of 
macrophages. 18b and CDC1551 was provided by Dr. Christopher Sassetti 
(University of Massachusetts Medical School) 
Method Details 
Aerosolized Mtb infection of mice 
Mice were infected by the aerosol route as previously described [16]. Frozen 
bacterial stocks were thawed and sonicated for 1 minute and then diluted into 5 ml 
of 0.01% Tween-80 in PBS. The diluted bacterial suspension was aerosolized to 
infect mice using a Glas-Col chamber (Terre Haute). The average number of 
bacteria delivered into the lung was determined for each experiment by plating 
lung homogenate from 4-5 mice 24 hours after infection and ranged between 40-
150 CFU/mouse. 
 
Intravenous 18b infection of mice  
Frozen bacterial stocks were thawed, sonicated for 1 minute, and resuspended 
with 0.01% Tween-80 in saline. 200 ul of bacterial diluent containing 2 x 107 CFU 
of 18b was intravenously injected into mice. 2 mg/mouse of streptomycin was 
given intraperitoneally everyday for the first week of infection. The average number 
of bacteria delivered into the lung was determined for each experiment by plating 
lung homogenate on 7H10 plated contained 50 ug/ml of streptomycin from 3 mice 
24 hours after infection and ranged between 105.9-106.5 CFU/mouse. 





Infected mice were monitored weekly in accordance with IACUC guidelines using 
the Body Condition Score (BCS) and serial weight determinations.  Mice with a 
BSC score less than or equal to 2 or had lost 20% body weight were euthanized. 
 
Bacterial burden in lung and spleen 
Infected mice were euthanized at pre-determined timepoints, and the left lung or 
whole spleen were homogenized using 2 mm zirconium oxide beads (Next 
Advance) in a FastPrep homogenizer (MP Biomedicals). Tissue homogenates 
were serially diluted and plated on 7H11 agar plates (Hardy Diagnosis). For 18b 
infection, tissue homogenates were plated on 7H10 agar plates contained 50 ug/ml 
of streptomycin. CFU was enumerated after 19-21 days of incubation at 37°C and 
5% CO2.  
 
Lung cell preparation 
Lungs were perfused with 10 ml of cold RPMI (Gibco) before removal. Single cell 
suspensions were prepared by homogenizing lungs using a GentleMACS tissue 
dissociator (Miltenyi), digesting with 300 U/ml collagenase (Sigma) in complete 
RPMI (10% FBS, 2 mM L-Glutamine, 100 units/ml Penicillin/Streptomycin, 1 mM 
Na-Pyruvate, 1X Non-essential amino acids, 0.5X Minimal essential amino acids, 
25 mM of HEPES, and 7.5 mM of NaOH) at 37°C for 30 minutes, and followed by 
a second run of dissociation using the GentleMACS. Suspensions were then 
sequentially filtered through 70 µm and 40 µm strainers.  
 
Intravascular staining 
Mice were injected intravenously with 0.2 ug/mouse of anti-CD45-AF647 in 200 ul 
of injection medium (2% FBS in PBS) 2 minutes before euthanizing with CO2. 
Lungs were then perfused and removed about 3 minutes after anti-CD45-AF647 
injection. Lymphocytes from blood collected in RPMI containing 40 U/ml of heparin 
were isolated using Lympholyteâ (CEDARLANE), and analyzed by flow cytometry 
to confirm uniform staining with anti-CD45-AF647.   
 
Flow cytometric analysis 
Cells were first stained with Zombie Fixable Viability dye (Biolegend) for 10 
minutes at room temperature (RT). For surface staining, cells were stained with 
antibodies in autoMACS running buffer (Miltenyi) containing 5 ug/ml of anti-mouse 
CD16/32 (BioXcell) for 20 minutes at 4°C. In some experiments, TB10.44-11 and/or 
32A309-318 tetramers were used with other antibodies. To measure transcription 
factor (TF) expression, cells were fixed and permeabilized for 30 minutes at RT, 
followed by staining for 30 minutes with antibodies to the different TF at RT using 
the Foxp3/TF staining buffer set (ThermoFisher). Samples were acquired on 
Aurora (Cytek) or MACSquant (Miltenyi). Flow data were analyzed using FlowJo 
v10.7.1, and FlowJo plugins UMAP v3.1 and PhenoGraph v3.0.  For UMAP 
projections of WT/KO CD8 T cells (i.e., Fig 3C and S2C), 2000 CD45iv-
CD44+CD62L- CD8 T cells/mouse from 5 WT and 5 MHCII KO mice were 
concatenated to one FCS file before creating UMAP projections. In UMAP 
projections comparing two models (i.e., Fig 5D), 2000 CD45iv-CD44+CD62L- CD8 
T cells/mouse from 5 WT and 5 KO, and 6 helped and 4 helpless mice from 
adoptive transfer model were concatenated and created UMAP projections. K= 
300 and K= 400 were used in PhenoGraph analysis in Fig 3D and Fig 5B, 
respectively, and the resulting clusters were overlayed onto UMAP projections. 
 
Adoptive transfer model 
Spleens and lymph nodes from C57BL/6J mice were mechanically disrupted onto 
70 µm strainers using the plungers of 3 ml syringes. CD8 T cells were then purified 
from cell suspensions using CD8a (Ly-2) microbeads (Miltenyi) and autoMACS 
separator (Miltenyi). Preparing cell suspension with same method, CD4 T cells 
were purified from spleens and lymph nodes of P25 mice using MojoSortTM CD4 
isolation kit and magnet (Biolegend). Purities of cells were determined for each 
experiment using flow cytometry. 2-5 million of CD8 T cells were transferred into 
TCRa KO mice with or without distinct congenic marked 105 P25 cells before 




Adoptive transfer with infected CD8 T cells 
Spleens of Mtb or 18b infected WT or MHCII KO mice were mechanically disrupted 
onto 70 µm strainers using the plungers of 3 ml syringes. CD8 T cells were then 
purified from cell suspensions using CD8a (Ly-2) microbeads (Miltenyi) and 
autoMACS separator (Miltenyi). Purities of cells were determined for each 
experiment using flow cytometry. 2-5 million of CD8 T cells were transferred into 
TCRa KO mice. TCRa KO mice received WT or MHCII KO CD8 T cells, and TCRa 
KO mice didn’t receive cells were challenged with aerosolized Mtb.   
 
In vitro CFU assay 
Purified CD8 T cells were cultured with infected macrophages to quantify their 
ability to inhibit Mtb growth. The assay is described in following sections: 
Preparation of Mtb: CDC1551 was grown in 7H9 media (supplemented with 10% 
OADC, 0.05% of Tween-80, and 0.2% glycerol) until an OD600 = 0.6-1, washed with 
RPMI, and opsonized with TB coat (RPMI 1640 containing 1% heat-inactivated 
FBS, 2% human serum, and 0.05% Tween-80). The bacteria were passed through 
5 µm filter to remove clumps and then enumerated by microscopy using a Petroff-
Hausser counting chamber. The concentration was adjusted to provide a 
multiplicity of infection (MOI) of 2.  
Macrophage collection and infection: Thioglycolate-elicited peritoneal 
macrophages (TG-PMs) were obtained by peritoneal lavage 3-5 days after 
intraperitoneal injection of mice with 3% thioglycolate, and purifying from the 
lavage using CD11b microbeads (Miltenyi) and LS columns (Miltenyi).  Purified 
TG-PMs were plated in NuncTM Up-CellTM 12-well plates (106/well), and once 
adhered, infected with CDC1551 overnight. Infected TG-PMs were detached and 
washed with cold complete RMPI, and re-seeded as 105/well in 96-well flat bottom 
plate before CD8 T cells were added.  
CD8 T cell isolation and co-culture: CD8 T cells were purified from the lungs of 
infected mice at indicated timepoints using CD8a (Ly-2) microbeads (Miltenyi) and 
an autoMACS separator (Miltenyi). The purity of cells was determined for each 
experiment and was typically 95%. Purified CD8 T cells were added to infected 
TG-PMs at a ratio 1: 2 (CD8 T: TG-PM) or as indicated. TG-PMs were lysed with 
1% Triton X-100 after 4-6 days of co-culture, and CFU was determined by plating 
serial dilutions of the lysate on 7H10 or 7H11 plates (Hardy Diagnosis). Percent 
inhibition by CD8 T cells was calculated as: 100 x (Mtb net growth without CD8 T 
cell – Mtb net growth with CD8 T cell)/ Mtb net growth without CD8 T cell. 
 
Cytokine production by CD8 T cells 
Lung CD8 T cells were isolated and cultured with macrophages infected with 
CDC1551 or H37Rv, as described above with the modifications that an MOI=5 was 
used and CD8 T cells were added into infected TG-PMs at a 1:1 ratio. Culture 
supernatants were collected after 18-24 hours of co-culture, and IL-2, IFNg, and 
TNF were assayed using LEGENDplexTM (Biolegend). 
 
RNA-seq 
CD8 T cells were collected and purified from lungs of infected mice 8wpi as 
described above. Purified CD8 T cells from individual lungs were suspended in 
RNAprotect® cell reagent (Qiagen) and the RNA extracted using RNeasy® mini 
kit (Qiagen). RNA samples were sequenced by GENEWIZ. Reads were aligned to 
the mouse genome and differential expression analysis performed by GENEWIZ. 
Gene Ontology analysis was performed with genes filtered with p-adjusted value 
(padj) < 0.05 and |log2 fold-change|³1, or filtered with padj < 0.05 independently of 
fold-change using R (v 3.6.1) package clusterProfiler (v3.14.3) [204]. The top 10 
enriched pathways with the highest padj value were presented. GSEA was 
performed using the Broad institute software and published datasets of CD8 
transcriptome from Gene Expression Omnibus (GEO) [205, 206]. Results 
comparing with datasets GSE30962 and GSE9650 were shown. 
 
In vivo antibody treatment 
100 ug of anti-CD40 (clone FGK45) was given intraperitoneally into infected MHCII 
KO mice once every week for 7 weeks. 100 ug of anti-Lag3 (clone C9B7W) 
antibody was given intraperitoneally into infected TCRa KO mice received WT or 
MHCII KO CD8 T cells every three days for 3 weeks. 200 ug of anti-CD4 was given 
intraperitoneally a day before and one day after 18b infection to deplete CD4 T 
cells in B57BL/6J mice, and 100 ug of anti-CD4 was continuously given every five 
days for 3 weeks.  
Quantification and Statistical Analysis 
Statistical analysis was performed using Graphpad Prism 8. P-values were 
calculated using unpaired t test, one-way ANOVA, or two-way ANOVA as indicated 
in the figure legends.  
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